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Embryonic stem cells (ESCs) have the capacity of self-renewal and 
differentiation into all somatic cell types. Because of these two features, ESCs 
are used in various studies on humans and animals. For a long time, there have 
been efforts to generate embryonic stem cells in cattle; however, genuine 
bovine ESCs have not been reported yet. In this study, bovine ESCs were 
generated using small molecules, and the properties of these cells were 
analyzed by various molecular biology techniques. In this study, small 
molecules that were suitable for the production of ESCs were selected, and the 
cultured cells were analyzed with the criteria for pluripotent stem cells 
including proliferation, pluripotency markers and differentiation abilities. 




differentially expressed genes were verified with Real-time PCR. The signaling 
pathways for pluripotency were analyzed by KEGG assay. The generated cells 
showed a monolayer flat shape and were positive for alkaline phosphatase 
staining. In addition, the cultured cells were able to proliferate and were 
maintained in a culture for over 50 passages with the normal karyotype and 
pluripotency. Although it was defined as embryo-derived stem-like cells 
(eSLCs) because of abnormal in vivo differentiation, the population of 
pluripotent cells expressing only the Oct4 or Nanog gene without Cdx2 
expression was confirmed in the eSLCs. As a result of the treatment with 
thiazovivin to improve the pluripotency, it was confirmed that the attachment 
rate of the blastocysts and the outgrowth rate increased significantly in the 
thiazovivin group compared with that of the control. Moreover, the expression 
of pluripotency related genes and E-cadherin genes were also increased in the 
thiazovivin group. However, it still failed to improve the potential of in vivo 
differentiation. Microarray analysis was conducted to analyze the limitations of 
the eSLCs. Tumor-related gene analysis showed that the expression of 
oncogenes decreased, while the expression of tumor suppressor genes increased. 
These results may be deeply related to the limitation of teratoma formation in 
the eSLCs. In addition, the TGFβ, WNT and LIF signaling pathways were 
found to be closely related to the maintenance of pluripotency in bovine. 
Different from the other two signaling pathways, the LIF signaling pathway 
was revealed as the inactive form. Thus, it is thought that the reactivation of the 
LIF signaling pathway may be the key to obtain true pluripotency in bovine. In 




using three inhibitors. In addition, while analyzing the characteristics of the 
cells, the limitations for retaining pluripotency in bovine were investigated. 
These results can help to improve our understanding of bovine pluripotency and 
contribute to establishing true ESCs in large animals. 
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REVIEW OF LITERATURE 
 
Embryonic stem cells  
Pluripotent stem cells (PSCs) have the capacity to self-renew by dividing and 
to develop into the three primary germ cell layers of the early embryo and 
therefore into more than 220 cell types in the adult body, but not extra-
embryonic tissues such as the placenta.  
ESCs are one of the typical PSCs and derived from the inner cell mass 
(ICM) of a blastocyst, an early-stage preimplantation embryo (Fig. 1A). In 1981, 
mouse ESCs (mESCs) were independently first derived from embryos [1]. The 
report revealed a new technique for culturing the mouse embryos in the uterus 
to allow for an increase in cell number, allowing for the derivation of ESCs 
from these embryos. In 1998, human ESCs (hESCs) are also derived from ICM 
of blastocyst [2]. Although ESCs were established from both mouse and human, 
they have very different culture conditions for supporting their pluripotency. 
Generally, the culture system for mESCs includes serum and leukemia 
inhibitory factor (LIF), while activin and fibroblast growth factor 2 (FGF2) 
were used for supporting pluripotency of hESCs (Fig. 1A). Recently, rat ESCs 
was also able to be maintained in vitro with two inhibitors [3]. It suggests that 
ESCs were derived from blastocysts in three different species, their 
pluripotency was not able to be supported by same culture strategy.  
Although stem cell research has been studied for decades, culture system 
for authentic ESCs were established in several rodents and human [1-3]. 






Figure 1. The establishment of embryonic stem cells (ESCs) and their 
pathways. (A) The generation of ESCs were usually derived from ICM of 
blastocyst. However, the medium conditions for ESCs were very different 
among species. Serum and LIF were used for mouse ESCs and Activin and 
bFGF were used for human ESCs. For rat ESCs, N2B27 and two inhibitors 
(Chir99021 and PD0325901). (B) Three different pathways, LIF, TGF and 
WNT, are related to pluripotency of ESCs. To maintain pluripotency in ESCs, 
the three pathways are able to activate pluripotent-associated core genes such 





pluripotency of induced pluripotent stem cells (iPSCs) which are devised by 
Takahashi and Yamanaka in 2006 [4]. In bovine, there have been many 
attempts to generate true ESC lines under culture condition modified either 
from mESCs or hESCs culture system [5-9].  
However, using the culture conditions, putative ESCs were generated, 
because of failure to meet rigorous criteria as PSCs. It suggests that the ESC 
culture systems for rodents and humans are inappropriate for supporting of the 
pluripotency and new approaches were required for bovine ESCs such as new 
culture system or investigation of transcriptome.  
The most important signaling pathways involved in the maintenance of 
pluripotency and the capacity for self-renewal in rodents and human are LIF, 
FGF and transforming growth factor (TGF)-β which acts through Smad2/3/4 
[10, 11] (Fig. 1B). The Wnt pathway also supports pluripotency by activating 
β-catenin [12]. These pathways result in the activation of three essential 
pluripotency-related transcription factors: Oct4, Sox2 and Nanog (Fig. 1B). The 
interaction among Oct4, Sox2 and Nanog regulates expression of pluripotent-
specific target genes to maintain the pluripotent state of the cells.  
Because properties such as self-renewal and multi-lineage differentiation 
potency [2] are common among ESCs from different species, understanding of 
the pluripotency control mechanism by exogenous factors in human or mouse 
embryonic PSC lines may be applicable in establishing large animal PSCs lines 
which have not been established yet. Recent study suggests that the regulation 
of FGF, mitogen activated protein kinase (MEK) and glycogen synthase kinase 




differentiation and growth inhibition in a variety of cell types including 
undifferentiated human ESCs [14]. In addition, various combinations of small 
molecules are able to block or support signaling pathways involving 
differentiation or maintenance of ESCs [3, 15]. In particular, FGF and 
extracellular signal-regulated kinase (ERK) signals led ESCs into neural or 
mesoderm differentiation, and GSK3 signals reduced activities of β-catenin, 
adhesive molecules and cell survival rate [11, 16-19]. The application of small 
molecules for bovine embryo-derived cells may be useful for the generation of 
genuine bovine ESCs. 
Although, genes involved in maintaining the pluripotent state are well 
characterized in mouse, the signaling pathways that regulate pluripotency in 
cattle have not been definitively identified. Recently, several groups published 
iPSCs from bovine differentiated cells, suggesting that the four factors may be 
also considered as key genes to retain pluripotent state in cattle [4, 20]. 
However, there are no studies available on successful application of shared 
culture condition between ESCs and iPSCs in bovine, implying that the medium 
for maintaining of iPSCs may be not sufficient to support pluripotency of ESCs. 
To understand suitable culture conditions for ESCs in bovine, it would be 
considered that investigations of broad-based gene expression patterns and 
finding of bovine specific-pluripotent genes are essential.  
 
Somatic cell nuclear transfer 
Somatic cell nuclear transfer (SCNT) is one of the powerful techniques for 




whole process was simply presented in Fig. 2. During the process of this 
technique, the nucleus of a somatic cell is transferred to the cytoplasm of an 
enucleated egg (an egg that has had its own nucleus removed). Once inside the 
egg, the somatic nucleus is reprogrammed by egg cytoplasmic factors to 
become a zygote (fertilized egg) nucleus. The egg is allowed to develop to the 
blastocyst stage. It has been reported that a SCNT blastocyst can develop fully 
and be born as a young of sheep in 1996, showing that SCNT technique is able 
to be considered to produce a viable cloning embryo functionally. 
In stem cell research, SCNT has become a focus of study in establishment 
of ESCs from therapeutic cloning embryos, which have potential regenerative 
medicine. A major consideration of ESCs as therapeutics is that they may 
trigger an immune rejection response when the ESCs are transplanted into a 
patient [21]. SCNT technology was originally developed for the multiplication 
of genetically high-valued animals, the rescue of endangered animal species, 
and the creation of genetically modified animals [22]. The technology has also 
been considered as a solution for obtaining patient-specific stem cells as it 
provides autologous ESCs genetically identical to the somatic cell donor [23]. 
Recently genuine SCNT-ESCs have been reported in human [24]. However, 
critical properties including immunogenicity and stability still need to be 
investigated [25]. 
In animal, SCNT-ESC technology is a useful tool for the conservation of 
endangered animal species and efficient production of transgenic animals [26, 
27]. In addition, researches of SCNT-ESCs in large animal species like cattle 










humans because of the similarities in surface markers and cellular 
morphologies between bovine ESCs (or ES-like cells) and human ESCs [5, 8, 
9]. Another technique for generation PSCs is iPSCs formed by forced 
expression of four transcription factors in somatic cells were introduced in 2006 
by Dr. Yamanaka and colleagues [4]. However, immunogenicity of iPSCs is 
still questionable [25], and abnormalities of iPSCs, which seem to occur during 
the reprogramming event, compromise genomic integrity by introducing de 
novo mutations and copy number variations [4]. Moreover, because the 




Microarray technology has revolutionized molecular biology, because of large-
scale studies of gene expression. The ability of these arrays to simultaneously 
interrogate tens of thousands of transcripts has led to important advances in 
tackling a wide range of biological problems, including the identification of 
genes that are differentially expressed between diseased and healthy tissues, 
new insights into developmental processes, drug discovery, toxicology studies, 
small molecule screening. Nonetheless, array technology has several 
limitations. For example, background hybridization limits the accuracy of 
expression measurements, particularly for transcripts present in low abundance. 
Furthermore, probes differ considerably in their hybridization properties, and 
arrays are limited to interrogating only those genes for which probes are 




most popular approach for transcript profiling and can be readily afforded by 
many laboratories.  
In stem cell research, microarray platforms were also used in various 
aspects such as exploring the microenvironment, profiling stem cell markers 
and tracking cell fate decisions. Until now, lots of transcriptome analyses of 
humans and mice have been profiled not only in embryo level but also in PSCs. 
However, there are some reports of microarray data in cattle at the pre-
implantation embryo level and no microarray data using bovine ESCs (bESCs) 
has been published.  
Different from mice and humans, studies of ESCs in cattle have been 
remained largely obscure. Moreover, most culture conditions using hESCs or 
mESCs were failed to support bovine ESCs, suggesting that the mechanism of 
pluripotency in cattle may be considerably different from hESCs or mESCs. 
Because of this situation, High-throughput screening assays are essential to 






There have been attempts to generate ESCs in domestic animals [8, 9]. From 
an agricultural perspective, the establishment of ESCs in domestic ungulates 
can provide a more efficient way to produce genetically-modified animals. 
Although the generation of ESCs in bovine has been attempted by many labs 
over the world [6, 28, 29], most methods have failed to support their 
pluripotency as stem cells including self-renewal and differentiation. Moreover, 
no studies have focused on the causes of these failures. Therefore, in the present 
study, I suggest a series of experiments for the following three topics to create 
a new approach to overcome these failures. 
 
1. The generation of bovine eSLCs by somatic cell nuclear transfer 
This topic has been largely reproduced from an article published, entitled “In 
vitro culture of stem-like cells derived from somatic cell nuclear transfer bovine 
embryos of the Korean beef cattle species, HanWoo” [30]. 
ESC technology is a useful tool in large animals for the conservation of 
endangered animal species and efficient production of transgenic animals [26, 
27]. Studies of SCNT-ESCs in large animal species like cattle can serve as a 
pre-clinical model for patient-specific stem cell therapies in humans because of 
the similarities in surface markers and cellular morphologies [5, 8, 9]. One of 
the most difficult challenges faced for SCNT-ESCs is the high incidence of 




cattle, most putative ESCs have been reported from in vitro fertilized or 
parthenogenetic embryos [5, 15, 26], while only one was from an SCNT 
embryo [9]. Although there have been many attempts to establish true ESC lines 
from bovine species under culture conditions modified either from mouse or 
human ESC culture protocols [5-9], only one study reported true ESC lines 
from in vitro-produced (IVP) bovine embryos [32]. Evidently, the ESC culture 
systems for mice and humans are suboptimal for the proliferation and 
maintenance of the pluripotency of bovine embryonic cells.  
Recently, several reports have been applied inhibitors of differentiation 
for maintaining bovine pluripotency [15, 33]. The double inhibition of MEK 
and GSK3 signaling enhances the expression of pluripotency-related genes 
without significant changes in the expression of trophoblast-related genes 
during embryonic development in bovine species [33]. In addition, ESCs from 
parthenogenetic bovine embryos were successfully generated under the culture 
system using MEK, GSK3 and FGF signaling inhibitors [15]. After several 
passages and cryopreservations, these parthenogenetic bovine cells expressed 
genes of pluripotency and were also capable of differentiation into three germ 
layers in vitro [15]. 
In the present topic, I demonstrate the generation of eSLCs originated 
from SCNT bovine blastocysts using the three inhibitors. These cells are 
genetically identical to the donors and have the capacity for self-renewal and 






2. Enhancing pluripotency of bovine eSLCs 
This topic has been largely reproduced from an article published, entitled 
“Thiazovivin, a Rho kinase inhibitor, improves stemness maintenance of 
embryo-derived stem-like cells under chemically defined culture conditions in 
cattle” [34]. 
Recent studies have shown that small molecules, Y-27632, a Rho-
associated kinase (ROCK) inhibitor, have a role in the maintenance of ESC 
properties, formation of iPSCs and the viability of stem cells after freezing and 
thawing. ROCK, a downstream target of Rho plays a role in cellular function 
through extracellular signaling. Inhibition of ROCK enhances the generation of 
human ESC from fair- or poor-quality (Grade Ⅲ and Ⅳ) cleavage stage 
embryos [35] and also induces the increase and the stabilization of the E-
cadherin protein at the plasma membrane of dissociated human ESC [36].   
Recently, thiazovivin is demonstrated to be a more potent ROCKi than 
Y-27632 in human ESC. Thiazovivin enhances the survival of dissociated 
human ESC on matrigel by regulating E-cadherin-mediated cell-cell interaction 
[37]. Furthermore, thiazovivin is more effective than Y-27632 in achieving a 
greater colony-forming efficiency and obtaining larger colony size in intestine 
stem cells [38]. 
E-cadherin is a transmembrane glycoprotein that mediates Ca2+-
dependent, homophilic cell-cell adhesion in the epithelial tissues including ESC 
[39]. Because it is co-expressed with other ESC makers in undifferentiated 
human ESC, it can be used as an undifferentiated cell marker to identify human 




efficiency, while knockdown of endogenous E-cadherin gene decreases 
reprogramming efficiency when generating iPSCs with Yamanaka’s four 
factors [41]. In addition, expression of the E-cadherin can compensate for by 
enhanced expression of the Oct4 gene, a critical factor for maintenance of 
pluripotency, during somatic cell reprogramming [42].   
In this topic, the purpose is to examine whether the treatment of 
thiazovivin can enhance the attachment and pluripotency to help the 
establishment of bovine eSLCs.  
 
3. Microarray analysis of bovine eSLCs 
This topic has been largely reproduced from an article published, entitled 
“Microarray analysis of embryo-derived bovine pluripotent cells: The 
vulnerable state of bovine embryonic stem cells” [43]. 
Cows are one of the most common and important domestic ungulates and 
are acknowledged as livestock for food and bioreactors [44]. There have been 
many attempts to establish ESCs in bovine species using general culture 
conditions for mESCs and hESCs [6, 28, 29]. However, those conventional 
methods are inappropriate for the survival of bESCs in vitro, as they lose their 
stem cell properties when involved in proliferation, pluripotency, or 
differentiation. These early efforts to generate bESCs were gradually 
discontinued due to less than promising results which showed that the majority 
of the cultured cell population lacked evidence of pluripotency or ability to 
sustain long-term growth.  




small molecules. Recently, eSLCs from bovine embryos were successfully 
generated using three inhibitors [30, 34]. Moreover, Cdx2, the trophoblast-
specific gene, is still expressed in the eSLCs. Recently, it has been reported that 
Cdx2-knockdown embryo-derived stem cells are generated and have similar 
characteristics to genuine PSCs [45] although only one cell line was 
successfully established from 59 embryos. So far, many studies have failed to 
isolate true ESCs. However, there is limited information about the key aspects 
that fail during the establishment of bESCs, and little is known about their 
transcriptomes and biological functions. Although the eSLCs in this experiment 
are not complete bESCs, analyses of these cells can contribute to our 
understanding of the characteristics of embryo-derived PSCs in cattle. 
To date, many genome-wide gene expression analyses of ESCs in 
humans and mice have been reported [46]. The early results of those 
microarrays were analyzed to verify the differences among various embryo 
resources, including IVP, parthenogenesis (PA), and nuclear transfer (NT) [47]. 
This technique has also been applied to compare somatic cells (SCs) with 
diverse stem cells from IVP, PA, and NT [48, 49]. Although two reports 
presented microarray data in cattle at the pre-implantation embryo level [50, 
51], there are no reports of microarray data using bESCs. 
In this topic, I investigated the global gene expression patterns of bovine 
eSLCs from three different origins, IVP-, NT- and PA-embryos, to validate their 
distinct characteristics including shared signaling pathways related to 
pluripotency. In addition, oncogenes and tumor suppressor genes were analyzed 




MATERIALS AND METHODS 
 
Chemicals 
Most inorganic and organic compounds were purchased from Sigma-Aldrich 
Korea (Yong-in, Korea) and all liquid medium and supplements were from Life 
Technologies (Grand Island, NY, USA) unless indicated in the text. 
 
Oocyte recovery and in vitro maturation (IVM) 
Bovine ovaries were collected from the Korean native beef cattle, HanWoo, at 
a local slaughterhouse (Livestock products market, Naju, Korea) and 
transported to the laboratory within 2-3 h of collection in saline at 25-35°C. 
Cumulus-oocyte complexes (COCs) were recovered by aspiration of 3 to 8 mm 
follicles. COCs that were enclosed by more than three layers of compact 
cumulus cells and an evenly granulated ooplasm were selected and incubated 
in IVM medium under warmed and gas-equilibrated mineral oil for 20-22 h at 
38.5°C under 5% CO2. The IVM medium for oocytes is composed of tissue 
culture medium 199 with Earle’s salts and L-glutamine (TCM199) 
supplemented with 10% fetal bovine serum (FBS; Thermo Fisher Scientific 
Korea, Seoul, Korea), 10 μg/ml FSH-P (Folltropin-VTM, Vetrepharm, 
Belleville, ON, Canada), 0.2 mM sodium pyruvate, 1 μg/ml estradiol-17β, and 
10 ng/ml epidermal growth factor. 
 
In vitro production (IVP) of bovine embryos 




Seosan, Korea) was deposited on the top of a discontinuous Percoll gradient 
prepared by depositing 2 ml of 90% Percoll under 2 ml of 45% Percoll in a 15 
ml centrifuge tube, and the sample was then centrifuged for 20 min at 252 x g. 
The pellet was removed and re-suspended in 300 μl of hTALP and centrifuged 
at 201 x g for 10 min. The active semen from the pellet was inseminated with a 
matured oocyte for 24 h (1 x 106 sperm cells/ml). After insemination, the 
cumulus cells were removed by repeated aspiration into a pipette and denuded 
fertilized oocytes were transferred to in vitro culture medium consisting of CR2 
with 0.3% ff-BSA and 1% ITS for 3 days. Oocytes were then transferred to CR2 
medium with 0.15% ff-BSA, 1% ITS, and 0.15% FBS for 5 days at 38.5°C in 
a humidified gas environment of 5% CO2, 5% O2, and 90% N2. 
 
Parthenogenesis and in vitro culture 
Parthenogenetic activation was performed after IVM of the oocytes. The 
oocytes were activated in 5 μM Ca-ionophore A23187 for 5 min, followed by 
2 mM 6-dimethylaminopurine (6-DMAP) for 3 h. After treatment, the activated 
oocytes were transferred and cultured in vitro as described above.  
 
Somatic cell nuclear transfer 
Matured oocytes were enucleated in HEPES-buffered TCM199 (hTCM199) 
supplemented with 20% FBS. The zona pellucida (ZP) was partially dissected 
with a fine glass needle to create a slit near the first polar body. The first polar 




chromosomes, were extruded by squeezing with the needle. The enucleated 
oocytes were placed and incubated in hTCM199 with 10% FBS before NT. A 
single donor cell isolated from ear skin tissue of the Korean native cattle, 
HanWoo, was injected into the perivitelline space of the enucleated oocyte 
through the slit made during enucleation. Then, karyoplast-cytoplast complexes 
were transferred into a cell fusion chamber with Zimmerman’s cell fusion 
medium and sandwiched between fine electrical rods. Cell fusion was 
accomplished with a single DC pulse of 25 V/mm for 10 μs. After 30 min of 
electric stimulation, fusion was confirmed under a stereomicroscope. The fused 
couplets were activated in 5 μM Ca-ionophore A23187 for 5 min, followed by 
2 mM 6-DMAP for 3 h. After treatment, the activated oocytes were transferred 
and cultured in vitro as described above.  
 
Generation of eSLCs 
ZP-free blastocysts were placed onto a mitomycin-C inactivated murine STO 
feeder cell layer and cultured at 38.5°C in a humidified gas atmosphere of 5% 
CO2 in 3i medium, which consists of equal volumes of DMEM/F12-
GlutamaxTM and neurobasal media with 1% (v/v) N2 and 2% (v/v) B27 
supplements plus the three inhibitors (3i): 0.8 μM PD184352 (Selleck 
Chemicals, Breda, Netherlands), 2 μM SU5402 (Tocris Bioscience, Ellisville, 
MO, USA), and 3 μM CHIR99021 (Tocris Bioscience). This was designated as 
passage zero (P0), and the medium was replaced every other day. After 10 days 




dissociated into 2-4 pieces from each clump, and each piece was re-plated onto 
fresh STO feeder layers and designated as P1. The colonies were passaged 
mechanically every 4 to 5 days. Only multilayered cells in the central region of 
the colony (CMt) were picked up for passaging eSLCs (Fig. 3). The peripheral 
monolayer part (PMn) were either discarded or separately cultured for 
comparative analysis. Each colony from IVP-, NT- and PA-embryos was 
labeled Ix-Py, Nx-Py, and Px-Py respectively along with its specific number x, Py 
the passage number.  
 
Treatment of thiazovivin  
To investigate the effect of thiazovivin, the 3iT medium is designed containing 
3i medium plus 2 μM thiazovivin. In a previous study it was demonstrated that 
ROCK inhibition with 2 μM thiazovivin is effective and comparable to 10 μM 
Y-27632 in human ESC [37]. 
 
Karyotyping 
Bovine eSLCs actively growing in log phase were treated with 0.1 mg/ml of 
colcemid for the induction of mitotic arrest. Cells were subsequently harvested 
by the standard cytogenetic methods of trypsin dispersal and hypotonic shock, 
and fixed using 3:1 methanol:acetic acid mixture. Mitotic cell slide preparations 
were analyzed by the G-banding method and interpreted by an investigator 






Figure 3. The scheme of in vitro culture cycle for passaging bovine somatic 
cell nuclear transfer embryo-derived stem-like cell (bSCNT-eSLC) colony. 
The methods for passaging the central multilayer (CMt) cell clump in bSCNT-
eSLC colony. (A) Whole SCNT-eSLC colony. The dotted circle displays CMt 
part. (B) Split colony into two clumps which include both CMt (arrowhead) and 
peripheral monolayer (PMn, arrow) regions. (C) CMt was manually separated 
from PMn in the clump using a 26 gauge needle. (D) A bSCNT-eSLC colony 
was divided into two layers, central multilayer (CMt) and peripheral monolayer 
(PMn). For passaging, the colony was cut into four to six pieces, and only CMt 
part of the slice was transferred to new feeder cell layer. In general, PMn part 
was discarded, except for comparative analyses of PMn versus CMt part cell 





Short tandem repeat (STR) loci analysis 
Donor somatic cells and bSCNT-eSLCs were used for independent 
microsatellite analyses. Genomic DNA was extracted from samples using the 
QIAamp DNA Mini Kit (Qiagen, Hilden, Germany). Samples were amplified 
in DNAmplify PE9700 following the technical manual of BiotraceTM bovine 
identification kit (Gendocs, Daejeon, Korea). Gene scan analysis on the 
amplified fragments was performed on an ABI 3130XL genetic analysis for the 
following microsatellite markers: Tgla227, Bm2113, Tgla53, Eth10, Sps115, 
Tgla126, Tgla122, Inra23, Eth3, Eth225 and Bm1824 (Applied Biosystems, 
Inc., Foster City, CA, USA). Each amplification reaction contained 1 μl DNA, 
2 μl primer mix, 4 μl PCR premix, 0.25 μl of Amplitaq Gold DNA polymerase 
and 2.75 μl sterile H2O. Final reaction volumes were 10 μl each. The cycling 
program started with an initial 11-min denaturation step at 95°C, followed by 
28 cycles of 1 min at 94°C, 1 min at 59°C, 1 min at 72°C, and the final extension 
step of 60 min at 60°C [52]. 
 
Proliferation Assays 
To determine the effect of 3i culture medium on cellular proliferation, 10 μM 
of 5-bromo-2'-deoxyuridine (BrdU) was added to the culture medium, and 
incubation was continued for 24 h. Before colony analysis, the colonies newly 
passaged and cultured in 3i system for 48 h to prevent contamination of BrdU-
positive bSCNT-eSLCs from the BrdU-positive feeder cells. Cells were fixed 




2 N HCl in PBS for 30 min at 45°C, equilibrated with 0.1 M borate buffer (pH 
8.5), and finally incubated with blocking buffer (20% Calf serum; 0.1% Triton 
X-100; 1% DMSO in PBS) for 2 h. Fixed cells were immunostained with 
antibodies against anti-BrdU mouse monoclonal antibody IgG (sc-32323, Santa 
Cruz Biotechnology Inc., Santa Cruz, CA, USA) followed by incubation with 
the secondary antibodies FITC conjugated goat anti-mouse IgG (A11001, Life 
Technologies). The treated cells were covered with slow-fade anti-fade with 
DAPI (SlowFadeGoldTM with DAPI, Life Technologies) for nuclear staining 
and covered with a glass coverslip. Images were captured with the fluorescence 
microscope (FV-300, Olympus). To examine cell doubling time, bSCNT-eSLCs 
were plated in 96-well flat-bottom plates at a density of 3x103/cm2 and cultured 
in 3i system with the BrdU CHEMICONTM Cell Proliferation Assay kit (2750, 
Millipore, Bedford, MA, USA) according to the manufacturer’s instruction. 
Absorbance was measured at 450 nm with a microplate reader (Model 550, Bio-
Rad, Hercules, CA, USA) from 4 to 40 h. 
 
Alkaline phosphatase (AP) and immunofluorescence staining 
The AP staining was performed using a commercial AP detection kit from 
Sigma. Immunofluorescence staining was performed according to standard 
protocols. Briefly, presumptive eSLCs from bovine SCNT blastocysts were 
fixed in 4% paraformaldehyde, permeabilized with 0.25% Triton X-100 and 
blocked with 1% goat serum in PBS. The fixed cells were immunostained with 
antibodies against octamer-binding transcription factor 4 (OCT4) (ab18976, 




protein (NANOG) (ab21603, Abcam), sex determining region Y-box 2 (SOX2) 
(MAB4343, Millipore, Bedford, MA, USA), stage-specific embryonic antigen-
4 (SSEA-4) (MAB4304, Millipore), tumor rejection antigen 1-60 (TRA-1-60) 
(MAB4360, Millipore), tumor rejection antigen 1-81 (TRA-1-81) (MAB4381, 
Millipore), caudal type homeobox 2 (Cdx2) (AM392, BioGenex, Fremont, CA, 
USA) and E-cadherin (1:100; ab11512; Abcam) followed by an incubation with 
FITC conjugated goat anti-mouse IgG (10 µg/ml; A11001, Life Technologies) 
or FITC conjugated anti-rabbit IgG (10 µg/ml; 65-6111; Life Technologies) or 
Cy3 conjugated anti-rat IgG (1 µg/ml; 112-1656-167; Jackson Immuno 
Research Lab Inc., West Grove, PA, USA) secondary antibodies. The treated 
cells were covered with slow-fade anti-fade with 4',6-diamidino-2-
phenylindole (DAPI) (SlowFadeGoldTM with DAPI, Life Technologies) for 
nuclear staining and covered with a glass coverslip. Images were captured with 
the fluorescence microscope (FV-300, Olympus, Tokyo, Japan). 
 
Formation of embryoid bodies (EBs) 
For EBs formation, bSCNT-eSLCs were harvested by treating with trypsin and 
transferred to 100 mm Petri dishes in DMEM containing 2 mmol/ml 
GlutamaxTM, 0.1% (v/v) β-mercaptoethanol, 1% (v/v) nonessential amino acid 
(NEAA), 1% (v/v) ITS, 1% (v/v) penicillin–streptomycin and 20% FBS at 
38.5°C in a humidified gas environment of 5% CO2 in air [15]. Culture medium 
was changed every 2 days. After 15 days of floating culture, non-attached EBs 





Reverse transcription PCR and Real-time PCR 
Total RNA from eSLCs, TE, ICM, whole blastocysts or EBs was extracted 
using the RNeasy mini kit (Qiagen), and M-MLV Reverse Transcriptase was 
used to synthesize cDNA according to the manufacturer’s instructions. The 
reaction (total volume 50 μl) for PCR contained 50 ng cDNA, 20 pmol each of 
specific primers, 1 μl Dimethyl sulfoxide (DMSO) if required and 25 μl 
Sapphire Amp fast PCR Master Mix (Takara, Otsu, Japan). Each thermal cycle 
for amplification included incubation at 98°C for 5 s, at 56°C for 5 s, and at 
72°C for 10 s; this cycle was repeated 35 times. PCR products were examined 
by 1% agarose gel electrophoresis. Nuclease-free water was also used as 
negative control. Real-time PCR was performed by 7500HT systemTM (Applied 
Biosystems) using SYBR Premix Ex Taq (Takara). PCR volume was 20 μl, 
containing 1 μl reverse transcript product. Cycling conditions were 1 cycle of 
95°C for 30 s and 40 cycles of 95°C for 5 s and 60°C for 30 s. The ΔΔCt method 
was used to determine relative quantitation of mRNA expression in samples, 
and fold change was determined as 2−ΔΔCt. The specific primer sequences 
representing pluripotency and three-germ layer differentiation marker genes are 
from previous reports [15, 53-55] and listed in Table 1. 
 
Teratoma formation 
Female nude mice of 6–8 weeks old were housed under pathogen-free 
conditions in a temperature controlled room on 12/12 h light/dark schedule with 




Table 1. Primer sequences for reverse transcription and real time 
polymerase chain reaction 











F: TTG GAC AGA TGC ACC AGC AA 
NM_001206039.1 
R: AGT CGG ACA AAG GCA TCC AG 
Dppa3 
F: AAAGCGGACGAGTATCGAGAAC NM_001111108.2 































































































































F: TCC AAC TGT GTG TCC CCA TC 
NM_001077878.2 















F: GGGTATTTGTAA AGATGAGCCCAG 
NM_001076121.1 


















































































































































management and surgical procedures were approved and performed under the 
guidelines of the Institutional Animal Care and Use Committee of Seoul 
National University (SNU-120321-7). To confirm pluripotency in vivo, 
bSCNT-eSLCs were delivered under the testis capsule of nude mice by 
injection (approximately 5 × 106 cells per site). Eight weeks after cell injection, 
mice were sacrificed, and the formed teratoma was extracted for histological 
examination. For immunohistochemistry, 4-μm-thick paraffin-embedded tumor 
tissue sections were stained with hematoxylin and eosin.  
 
Microarray gene expression analysis 
For microarrays, the synthesis of target cRNA probes and hybridization were 
performed using Agilent’s Low RNA Input Linear Amplification kit (Agilent 
Technologies, Palo Alto, CA, USA) according to the manufacturer’s 
instructions. The fragmented cRNA was resuspended with 2X hybridization 
buffer and directly pipetted onto the assembled Agilent’s Bovine Oligo 
Microarray (44K). The arrays were hybridized at 65oC for 17 h using the 
Agilent Hybridization oven and the hybridized microarrays were washed as 
described in the manufacturer’s washing protocol (Agilent Technologies). The 
hybridized images were scanned using Agilent’s DNA microarray scanner and 
quantified with Feature Extraction Software (Agilent Technologies). All data 
normalization and selection of fold-changed genes were performed using 
GeneSpringGX 7.3 (Agilent Technologies). The averages of normalized ratios 
were calculated by dividing the average of the normalized signal channel 




Hierarchical clustering was performed with TIGR MeV Ver.4.9 software 
(Institute of Genomic Research, Rockville, MD, USA) [56]. Microarray data 
are available from Gene Expression Omnibus (GEO, http://www. ncbi. 
nlm.nih.gov/geo/) with the accession number GSE92672.  
 
Gene Ontology (GO) annotation analysis 
The functional annotation analysis of the co-up and downregulated gene lists 
was carried out using the Database for Annotation, Visualization and Integrated 
Discovery (DAVID, http://www.david.abcc.ncifcrf.gov/) based on GO 
annotation [57], as well as GO terms of BP, MF and CC. The annotation with a 
false discovery rate (FDR) was adjusted. P <0.05 was considered significant. 
 
Statistical analysis 
All values are expressed as mean ± SD. To determine significance between two 
groups, comparisons were made using Student’s t-test by Graphpad Prism V5.0 









1. The generation of bovine eSLCs by somatic cell nuclear transfer  
 
Optimization of culture condition for bovine eSLCs by 
various combination of inhibitors 
To find proper culture condition for bovine eSLCs, IVF bovine blastocysts were 
seeded and cultured under several combinations of PD184352, SU5402 and 
CHIR99021. Among all combination groups tested, only 3i combination group 
was able to maintain bovine eSLC colonies over 20 passages (Table 2).  
 
Embryo production and the generation of bSCNT-eSLC colonies 
SCNT bovine embryos showed normal development up to the blastocyst stage 
in vitro. The ZP-free blastocysts were obtained mechanically by mouth-
pipetting (Fig. 4A) and seeded onto the feeder layer with 3i culture medium. 
The rate of attachment and primary colony formation were evaluated. Initially,  
2 or 3 blastocysts were seeded into each well, and 7 different eSLC colonies 
were generated from 21 ZP-free blastocysts in the 9 different wells (Table 3). 
Most ZP-free blastocysts were attached on the feeder layer within 3 days after 
seeding, and the primary colonies started to appear after that. In Group 1 where 
2 embryos were seeded in each well, 7 out of the 12 blastocysts successfully 





Table 2. Comparison of various bovine embryonic stem cell culture media  
 No. of stem cell colonies at*  
 Passage 0** Passage 3 Passage 5 Passage 11 Passage 15 
PD184352 5 1 0 0 0 
CHIR99021 5 1 1 0 0 
SU5402 +  
CHIR99021 
5 3 1 0 0 
PD184352 +  
CHIR99021 
5 3 2 2 0 
3i** 22 22 21 20 20 
*When passaging, only one piece of four slices of the colony, which had been selected 
randomly, was passaged and maintained for this experiment. 
** Three blastocysts per well 







Figure 4. Generation of bovine somatic cell nuclear transfer embryo-
derived stem-like cell (bSCNT-eSLC) colony. (A) Zona-pellucida-free 
blastocysts. The arrow indicates the intact ICM. (B) A primary bSCNT-eSLC 
colony. The arrow indicates central multilayer (CMt) part and the arrow head 
points to the boundary between the feeder cell layer and the peripheral 
monolayer (PMn) part of the eSLC colony. (C) The colony at passage 20 and 
(D) high magnification picture of the cell colony. The circle indicates the 
multilayer part of the bSCNT-eSLC colony. (E) Split cell slices for passaging. 
Only the central multilayer portion of the slice (dotted rectangle and small 
picture box at bottom-left) was collected for passaging. (F) Example of a colony 





Table 3. Generation of bovine somatic cell nuclear transfer embryo-
derived stem-like cells in multi-embryo seeding groups 
 
 Group 1a Group 2b Total 
No. of total embryos 12 9 21 
No. of total wells 







No. of outgrown primary colonies (%) 7 (58.3) 7 (77.7) 14 (66.6) 
No. of stem cell lines over passage 50 (%) 4 (33.3) 3 (33.3) 7 (33.3) 
aTwo blastocysts per well 





7 out of 9 blastocysts attached (77.7%) on the feeder layer cells. In this 
experiment, every attached blastocyst grew well and formed a primary colony. 
This is comparable to the previous reports (13-67%) [29].  
Although most previous studies also used a multi-embryo seeding method 
[6, 58-60], here, I attempted single-embryo seeding for the creation of single 
custom stem cell lines, because it is important for various future applications 
based on individual genetic traits. Hence, bSCNT-eSLC colonies were 
generated from the single-seeding group where only one ZP-free blastocyst was 
seeded in each well. In total, 8 out of 11 ZP-free blastocysts attached well on 
the feeder layer, and all of those grew successfully (Table 4). In this 
experimental group, the rate of primary colony formation was 72.7%, which 
was comparable to the multi-seeding groups (66.6%; Table 3). Moreover, all 
primary colonies developed into eSLC colonies, which went over P50. The 
efficacy of cell colony establishment was more than two times higher in the 
single seeding group than in the multi-seeding group (72.7% vs. 33.3%).  In 
the same way, IVF and parthenogenetic single-embryo seeding were also able 
to generate eSLC colonies (Table 5). 
 
Morphology of bSCNT-eSLC colonies 
A primary bSCNT-eSLCs colony is spherical in shape with well recognized 
boundaries (Fig. 4B). The primary colony is quite large in its size and similar 
to a human ESC colony [2]. The colony can be divided into two morphological 
regions, CMt and PMn (Fig. 4B). Cells from CMt are smaller and more 




Table 4. Generation of bovine somatic cell nuclear transfer embryo-





No. of attached 
blastocysts (%) 
No. of primary 
colonies (%) 
No. of stem cell 
lines over 
passage 50 (%) 
1 6 4 (66.6) 4 (66.6) 4 (66.6) 
2 5 4 (80.0) 4 (80.0) 4 (80.0) 






Table 5. Comparison of various bovine embryonic stem cell culture media  
 No. of stem cell colonies at*  
 Passage 0 Passage 3 Passage 5 Passage 11 Passage 15 
PD184352 5 1 0 0 0 
CHIR99021 5 1 1 0 0 
SU5402 +  
CHIR99021 
5 3 1 0 0 
PD184352 +  
CHIR99021 
5 3 2 2 0 
3i** 22 22 21 20 20 
*When passaging, only one piece of four slices of the colony, which had been selected 
randomly, was passaged and maintained for this experiment. 





(Fig. 4C, D); these morphologies correspond with previous reports [58, 61]. 
During passaging, the CMt cells were separated and interposed randomly 
within the middle of the colony but can still be discriminated from the 
monolayer portion. Only the CMt cells were selected to generate and propagate 
progeny colonies (Fig. 3 and Fig. 4E). The progeny colonies maintained their 
PSC characteristics, including a CMt and a PMn with clear boundaries. If the 
colony showed unclear CMt, unexpected cystic cavities (Fig. 4F), or various 
differentiated cell types were found, the colony was discarded. 
 
Cytogenetic and molecular characteristics of bSCNT-eSLCs 
All established bSCNT-eSLC colonies were maintained in culture over 50 
passages for more than 270 days with normal karyotypes consisting of 60 
chromosomes at P50 (58XX, Fig. 5A). Microsatellite DNA analyses examining 
eleven loci to confirm that the bSCNT-eSLC colonies are genetically identical 
to the donor fetal fibroblasts used for SCNT (Fig. 5B).  
The presence of BrdU-positive cells in the CMt region of the colony during 
passaging was observed, indicating that bSCNT-eSLCs are able to proliferate 
under the 3i culture system after repetitive subculture (Fig. 6A). ESC must meet 
several criteria; at a bare minimum is alkaline phosphate (AP) staining analysis. 
The bSCNT-eSLCs identified in this study are positive to AP activity regardless 
of their morphological differences, although cells from the CMt display much 
stronger AP activity (Fig. 6B). In addition, expression of pluripotency and TE 
specific markers were also confirmed by RT-PCR analysis (Fig. 6C).  






Figure 5. Cytogenetic characteristics of bovine somatic cell nuclear 
transfer embryo-derived stem-like cell (bSCNT-eSLC) colonies. (A) A 
normal karyotype consisting of 60 chromosomes (58XX) at P55 (N2P55; N2 
line at passage 55). (B) Microsatellite DNA analyses examination of eleven loci 
of Tgla227, Bm2113, Tgla53, Eth10, Sps115, Tgla126, Tgla122, Inra23, Eth3, 
Eth225 and Bm1824 confirm that the bSCNT-eSLC colony is genetically 













Figure 6. Molecular characteristics of bovine somatic cell nuclear transfer 
embryo-derived stem-like cell (bSCNT-eSLC) colonies. (A) 5-bromo-2'-
deoxyuridine (BrdU) labeling of bSCNT-eSLC colony at P30 (N2P30). BrdU-
positive cells are revealed in both peripheral monolayer (ⅰ-ⅲ) and central 
multilayer (ⅳ-ⅵ) regions. All enlarged pictures (ⅰ-ⅵ) were from the dotted 
circles in the colony (ⅶ). (B) Alkaline phosphatase activity assay at P30 
(N2P30). The bSCNT-eSLC colonies were positive for AP activity across the 
whole colony regardless of their morphological differences. The central 
multilayer portion displayed much stronger AP activity. STO cells were 
negative control. (C) Expression of the pluripotency and trophectoderm specific 
marker genes by RT-PCR analysis in bSCNT-eSLCs at P20 (N2P20) and P35 
(N2P35), inner cell mass (ICM), trophoblast (trophectodermal cell; TE), whole 
embryo (whole), STO (feeder) and bovine fibroblast (BF as nuclear donor). The 
pluripotency markers were also classified naïve, core and primed in accordance 




Nrob1 and Fgf4) and core-pluripotency related factors (Oct4, Nanog, Dppa3 
and Dppa4) were highly expressed in the bSCNT-eSLCs. Among the primed 
state PSC markers, however, only Fgf5 showed expression whereas T-
brachyury and Lefty2 were not expressed. These cells also expressed some 
typical TE specific markers such as Cdx2, Tead4 and Ifn-tau whereas other TE 
markers, Elf5 and Hand1, were not expressed.  
All specific marker genes were not expressed in either the STO feeder cells 
or bovine adult fibroblasts used as nuclear donors. In TE from the blastocysts, 
only Oct4, Dppa3, Fgf4 and TE specific markers were expressed. 
Immunofluorescence analysis indicates that the bSCNT-eSLCs were positive to 
the pluripotency markers such as OCT4, SOX2, NANOG, SSEA-4, TRA-1-60 
and TRA-1-81 (Fig. 7). Positive expression of immunofluorescence markers 
was generally concentrated in and around the CMt. 
 
In vitro and in vivo differentiation of bSCNT-eSLCs 
To demonstrate in vitro differentiation potential of the eSLCs, EBs were formed 
from bSCNT-eSLCs and both cystic and solid types of EBs were obtained (Fig. 
8A). Then, the generated EBs were analyzed by RT-PCR for specific markers 
of ectodermal, endodermal and mesodermal genes as well as for pluripotency 
genes (Fig. 8B). To confirm their in vivo differentiation potency, teratoma 
formation induction was attempted by introducing bSCNT-eSLCs under the 
testis capsule of nude mice. The transplanted cells formed exophytic tumorous 
mass (Fig. 9A, B). Even though after 8 weeks of cell introduction the tumors 





Figure 7. The images from immunofluorescence assay at P30. Bovine 
somatic cell nuclear transfer embryo-derived stem-like cells (bSCNT-eSLCs) 
are positive for the pluripotency markers OCT4, SOX2, NANOG, SSEA-4, 
TRA-1-60 and TRA-1-81. Fluorescence is generally highlighted in and around 
the central multilayer area. STO (feeder) and bSCNT-eSLCs without primary 
antibody were used as negative controls (STO-NC and eSLC-NC, respectively). 






Figure 8. In vitro differentiation of bovine somatic cell nuclear transfer 
embryo-derived stem-like cells at P31 (N2P31). (A) Formed embryoid bodies 
(EBs) after 10 day of floating culture. The arrow and arrowheads indicate solid 
part and cystic part of EBs respectively. Scale bar = 100 μm. (B) Gene 
expression analyses of EBs by RT-PCR. The three germ layer specific markers 
of ectodermal (β-3-tubulin, Nestin and Vimentin), endodermal (Somatostain, 
Tansthyretin and α-Fetoprotein) and mesodermal (Connexin40 and Bmp4) 
genes were expressed, while pluripotent marker genes of Oct4 and Nanog were 






Figure 9. In vivo differentiation of bovine somatic cell nuclear transfer 
embryo-derived stem-like cells (bSCNT-eSLCs) at P31 (N2P31). (A and B) 
The embryonic carcinoma formed under the testis capsule of a nude mouse. (C) 
Representative histologic feature of the bSCNT-eSLC-derived embryonic 
carcinoma. The tumor consists of large primitive cells with areas of glandular 
(D) and papillary (E) formations. (F) The nuclei were large and overlapping, 
and prominent multiple nucleoli were present. Hematoxylin and eosin staining; 





typical embryonal carcinomas (Fig. 9C) formed by large primitive cells with 
areas of glandular (Fig. 9D) and papillary formations (Fig. 9E). The nuclei were 
large and overlapping, and nucleoli were multiple and prominent (Fig. 9F). 
 
Comparative analysis of CMt and PMn 
Since both pluripotency and TE specific marker genes are expressed in bSCNT-eSLCs, 
specific lineage markers of OCT4, NANOG and CDX2 were analyzed by 
immunofluorescence staining to localize the marker protein expression within the 
colony (Fig. 10). Although OCT4 and CDX2, or NANOG and CDX2 were largely co-
localized throughout the whole colony (arrowheads, Fig. 10B, F), OCT4- or NANOG-
only positive cell population without CDX2 expression also existed in CMt region of 
the colony (arrow, Fig. 10B, F). For the verification of more specific stem cell 
properties of the colony, cell population from CMt and PMn regions were separately 
passaged and analyzed. The colony derived from CMt presented small and condensed 
cells, whereas the colony from PMn revealed large and flat epithelial-like cells (Fig. 
11A). The outgrowth rate and the number of AP-positive colonies were also 
remarkably different between two regions (Table 6 and Fig. 11B, C). Most colonies 
from CMt were able to outgrow while the large portion of colonies from PMn failed 
to maintain after passaging (80% vs. 25%) in this 3i culture condition. The AP staining 
results also showed that the numbers of AP-positive colonies from CMt are much 
higher than those from PMn (100% vs. 10%). The expression levels of pluripotency 
genes (Oct4, Nanog and Sox2) in CMt were significantly higher than those in PMn by 
Real-time PCR analysis, while the expression pattern of TE genes (Cdx2, Tead4, 






Figure 10. Immunofluorescence image of lineage specific marker 
expression in the central multilayer (CMt) part cells of the colony at P30 
(N2P30). (A-C) Images from OCT4 (red) and CDX2 (green) stained cells. 
Nucleus was stained with DAPI (blue) (D) Distribution of OCT4 and CDX2 
expressing cells in normal bovine blastocyst as positive control. (E-G) Images 
from NANOG (red) and CDX2 (green) stained cells. Nucleus was stained with 
DAPI (blue) (H) Distribution of NANOG and CDX2 expressing cells in normal 
bovine blastocyst as positive control. The arrowhead indicates the OCT4- or 
NANOG-positive cells with CDX2 expression. The arrow indicates OCT4- or 





Table 6. Comparison of outgrowth rate and alkaline phosphatase activity 
between central multilayer cells and peripheral monolayer cells  
 No. of passaged colonies 
 Total 
AP positive  
Outgrowth (%) 
Strong (%) Weak (%) 
Central 
multilayer cells 
20 15 (75) 1 (25) 16 (80) 
Peripheral 
monolayer cells 






Figure 11. The comparison of central multilayer (CMt)-derived colonies 
and peripheral monolayer (PMn)-derived colonies after passaging. (A) The 
morphology of CMt-derived (Left) and PMn-derived passaged colony (Right). 
The arrow indicates small and condensed cells which are generally found in 
CMt. The arrowhead indicates large and flat cells generally found in PMn. (B 
and C) Alkaline phosphatase (AP) activity assay demonstrates that (B) most 
CMt-derived passaged colonies exhibit strong AP activity (C) while only few 







Figure 12. Quantitative gene expression analyses of central multilayer 
(CMt) and peripheral monolayer (PMn) parts of the colony at P31 (N2P31). 
The expression of pluripotency (Oct4, Nanog and Sox2) and trophectoderm 
(Cdx2, Tead4, Gata3 and Ifn-tau) markers were analyzed by real-time PCR. 
The cells in CMt part have higher expression of pluripotency specific marker 
genes than those in PMn part, whilst TE specific marker expression shows the 
opposite results. Data were normalized to the expression level of GAPDH 





2. Enhancing pluripotency of bovine eSLCs 
 
The effect of thiazovivin on attachment 
The ICM, TE or whole blastocyst at Days 7 to 9 was seeded and attached to the 
feeder layer, either in 3i or 3iT medium, and the rates of the attachment and the 
primary colony formation were evaluated. The attachment rates of the ICM, TE 
or whole blastocyst in 3iT medium (90.0%, 70.0% and 80.8%, respectively) 
were significantly greater (P < 0.05) than the rates in 3i medium (50.0, 40.0T 
and 46.2%, respectively). The formation rates of primary colonies from total 
seeded blastocysts in 3iT medium (50.0%, 35.0% and 76.9%, respectively) 
were also greater (P < 0.05) than the rates in 3i medium (25.0%, 25.0% and 
38.5%, respectively). Neither the 3i nor 3iT culture conditions supported the 
proliferation of the TE-only part (data not shown), and among all experimental 
groups, the greatest yield of primary colonies was obtained from the 3iT 
medium group of the whole blastocyst seeding (Table 7). The results indicate 
that when generating eSLCs of cattle, cellular attachment and formation of 
primary colonies on the feeder layer can be increased by the whole blastocyst 
seeding and the thiazovivin treatment, using 3i medium condition.  
 
The effect of thiazovivin on generation of eSLCs 
The primary colonies achieved the outgrowth stage on the Day 7 of culture,  
when these colonies were passaged (Fig. 13). The colonies displayed a flat 
shape, were large in size and similar to a human ESC colony. The colony could 









No. of total 
blastocysts 
No. of attached/total 
blastocysts (%) 









Whole 26 12 (46.2)a 10 (38.5)a 83.3 a 
ICM 20 10 (50.0)a 5 (25.0)a 50.0 b 




Whole 26 21 (80.8)b 20 (76.9)b 95.2 a 
ICM 20 18 (90.0)b 10 (50.0)c 55.6 b 
TE 20 14 (70.0)b  7 (35.0)a 50.0 b 
† Three Biological replicates 
*3iT: 3i culture medium supplemented with thiazovivin 
**Part of embryos when seeding on feeder layer. Whole: zona pellucida-free whole 
embryo; ICM: inner cell mass part; TE: trophectoderm part 





Figure 13. Morphology of embryo-derived stem-like cells (eSLCs) of cattle.   
(A)  A good quality blastocyst after 7 days of in vitro fertilization (IVF). (B) 
Zona pellucida-free IVF blastocysts. (C) Blastocysts mounted on a STO feeder 
layer. Primary outgrown colony from the mounted blastocyst cultured in the 
medium containing either 3i (D) or 3i with thiazovivin (E). eSLC colony at 
passage 25 maintained in medium containing either 3i (F) or 3i with thiazovivin 




peripheral monolayer. The ES-like cell colonies at P15 were split by the 
mechanical method and cultured either in 3i or 3iT medium for passaging. The 
formation rate of outgrown colonies from the split putative colony that clumps 
in 3iT medium was greater than that in 3i medium after a subculture to P15. 
Therefore, thiazovivin treatment tends to reinforce putative colony outgrowth 
and supports the expansion of eSLC cultures during the subculture for 
passaging (Table 8). 
 
Characterization of eSLCs 
The putative eSLCs were passaged to P25 and the expression of pluripotency-
related genes was analyzed by RT-PCR and qPCR. Under 3iT culture conditions, 
the expression of the pluripotency marker genes of Oct4 and Nanog were 
greater than those under 3i control conditions (Fig. 14A, B). Naïve and primed 
pluripotency state-related markers were also analyzed. Naïve state markers 
were expressed in both groups, while T and Lefty2, the primed state markers, 
were not expressed (Fig. 14C). The eSLC colonies from both experimental 
groups were tested for the maintenance of an undifferentiated state by AP 
staining. The AP activity assays were positive in both groups (Fig. 15A, B). The 
ES cell-specific marker proteins such as OCT4, NANOG, SOX2 and TRA-1-
60 were detected by immunofluorescence staining. The markers were all 
positive in the cultured colonies from both experimental groups (Fig. 15C-L). 
In the BrdU assay, the central part of eSLC colonies presented a BrdU-positive 
cells population (Fig. 16) and this confirmed the existence of actively growing 




Table 8. Effect of thiazovivin on outgrowth of primary colonies during in 
vitro culture†  
Group 
No. of putative  
colony clumps 
No. (%) of  
outgrown colonies 
3i  35 20 (57.1)a 
3iT 35 31 (88.6)b 
†Four Biological replicates 
*3iT: 3i culture medium supplemented with thiazovivin 






Figure 14. Gene expression analyses of pluripotency markers after 
thiazovivin treatment in culture. (A) Real-time quantitative PCR analysis of 
the pluripotency genes, Oct4 and Nanog. All values are depicted as the level of 
expression relative to the 3i control group (values in 3i group = 1). Data 
represent means ± S.E.M from three experiments (n=3). The expression of the 
pluripotency marker genes Oct4 and Nanog was greater in the thiazovivin 
supplemented (3iT) group (P <0.05).  (B) The results of RT-PCR analysis also 
show that the 3iT group tends to express both pluripotency marker genes. (C) 
Naïve and primed pluripotency state marker genes were analyzed in 3i and 3iT 
groups by RT-PCR eSLCs at passage 25. Most marker genes are expressed in 





Figure 15. Immunofluorescence and alkaline phosphatase (AP) staining 
images of putative eSLCs of cattle cultured with or without thiazovivin. 
The cells cultured in the medium containing 3i only (A-D, K) or 3i with 
thiazovivin (E-H, L). (A-H) eSLC colonies were stained with OCT4, NANOG, 
SSEA-4 and TRA-1-60 antibodies as makers of embryonic stem cells (green) 
and with DAPI as a nuclear marker (blue). (I) Negative control without primary 
antibody. (J) STO cells as the feeder for eSLCs showing AP-negative. (K, L) 
The result of AP staining of cells (red); X40 (left) and X200 (right). All markers 
were positive in cultured colonies from both experimental groups. Scale bar = 






Figure 16. Proliferation of eSLCs of cattle. BrdU assay of eSLCs at passage 
25. Central part of eSLC colony with dome-like shape (A) possessing BrdU-
positive cell population (green; B, C). (D) Negative control without primary 
antibody. (E) Mitomycin C-treated STO cells showing BrdU-negative. Scale 





Detection of E-cadherin protein and gene in eSLCs  
Immunofluorescence staining was performed to detect E-CADHERIN protein 
and qPCR analysis was conducted to analyze the expression of the E-cadherin 
gene in the eSLCs. The greater amount of E-CADHERIN protein was detected 
in the 3iT group compared with the 3i control group (Fig. 17A, B). The 
expression of the E-cadherin gene was also increased in the 3iT group when 
compared with the 3i control group (Fig. 17D). 
To confirm the ability of eSLCs to differentiate into three developmental 
lineages in vitro, EBs were made from eSLCs via floating culture on low 
attachment plates for 15 days (Fig. 18A). Both cystic and solid types of EBs 
were formed from the culture (Fig. 18A) and solid type EBs were used for RT-
PCR analysis. The pluripotency-related genes, Oct4 and Nanog, were not 
detected whereas lineage-specific marker genes were expressed in EBs. The 
EBs derived from eSLCs treated with thiazovivin treatment tended to have 
greater expression of ectodermal lineage-specific genes than those derived from 
cells cultured without thiazovivin. In contrast, the result of endodermal lineage 
marker expression analyses was vice versa (Fig. 18B).  
 
3. Microarray analysis of bovine eSLCs 
 
Comparison of eSLCs and somatic cells (SCs) 
To analyze the microarray data, I selected six different bovine eSLCs from three 




Figure 17. E-cadherin expression in putative eSLCs of cattle cultured with 
or without thiazovivin. Immunofluorescence staining images of E-
CADHERIN (red) and DAPI (blue) in eSLCs. Cells were cultured in medium 
containing 3i only (A) or 3i with thiazovivin (3iT) (B) and negative control 
without primary antibody (C), X100. Higher levels of E-CADHERIN protein 
were detected in 3iT group compared with the 3i control group. (D) The 
expression of the E-cadherin gene was analyzed by real-time quantitative PCR 
(n=3). Values depicted by the rate to the expression in 3i control group (values 
in 3i group = 1). Data represent means ± S.E.M from three experiments. The 







Figure 18. Formation and characterization of embryoid bodies (EBs) from 
putative eSLCs of cattle. (A) The EBs were formed by floating cultures of 
eSLCs maintained either in 3i or 3i with thiazovivin (3iT). The cell aggregates 
displayed a spherical morphology (solid and cystic type) in both experimental 
groups. Arrow represents the cystic part and Arrow head do the solid part. (B) 
Expression analysis of three germ layer marker genes in EBs of solid type by 
RT-PCR; Ectodermal (Beta-3-tubulin, Vimentin and Nestin), Mesodermal 
(Connexin40 and Bmp4), Endodermal lineage-related genes (Somatostatin, 
Gata6 and Transthyretin) and pluripotency–related genes, as well as 
pluripotency markers Oct4 and Nanog. The EBs formed in the 3iT group tended 
to have greater expression of ectodermal lineage specific genes whereas the 
result of endodermal lineage marker expression was vice versa. Negative 





PA blastocysts. The lists of differentially expressed genes (DEGs), determined 
using an absent/present (A/P) classification and ≥ 2-fold difference as cut-offs, 
are available from GEO with the accession number GSE92672, and 10,203 
genes were selected (Fig. 19A). 
The selected 10,203 genes were used to compare groups. To improve the 
accuracy of gene expression alteration as DEGs, I compared the normalized 
single value of each sample and the average value of each sample. Finally, 
significant differences in gene expression were confirmed by real-time PCR. 
To investigate characteristics of bovine eSLCs, they were compared with 
SCs. Hierarchical clustering with the 10,203 genes showed that there was little 
difference in gene expression among the six different eSLCs. Conversely, all 
eSLCs had significantly different gene expression from SCs (Fig. 19A).  
 
Differences between eSLCs and SCs  
To further investigate specific differences between eSLCs and SCs, eSLCs from 
IVP-blastocysts (IVP-eSLCs) were selected as typical eSLCs, because they 
originated from an IVP-blastocyst produced by a sperm and an oocyte, similar 
to normal fertilization in vivo. When I compared IVP-eSLCs and SCs, 3,414 
genes were observed as DEGs: 1,552 of those genes were up-regulated and 
1,862 genes were down-regulated (Fig. 19B). There were 289 GO terms in the 
BP group that were enriched by adjusting the FDR (P<0.05) for up-regulated 
genes. The 10 dominant GO terms were listed and the most of them (9 of 10 
terms) were related to metabolic activity or cell cycle (Fig. 19C). There were 













Figure 19. Comparison of gene expression between embryo-derived stem-
like cells (eSLCs) and somatic cells (SCs) in cattle. (A) Hierarchical cluster 
of in vitro production (IVP)-, nuclear transfer (NT)-, parthenogenesis(PA)-
eSLCs, and SCs. The gene expression pattern from three eSLCs are countlessly 
different from SCs. (B) Venn diagram of all differently expressed genes (DEGs) 
in IVP-eSLCs and SCs. (C) Top 10 biological processes associated with 
significantly up-regulated and down-regulated genes in IVP-eSLCs and SCs. 
(D) Venn diagram of DEGs related to pluripotency in IVP-eSLCs and SCs. (E) 
Gene expression profiles of representative genes related to pluripotency. These 
genes are highly expressed in three eSLCs, compared with the genes in SCs. 





(P<0.05) for down-regulated genes. The 10 dominant GO terms were listed and 
the many of them (6 of 10 terms) were related to development or cell 
differentiation (Fig. 19C).  
To further investigate the properties of cultured IVP-eSLCs, I also analyzed 
pluripotency related genes. During the analysis, the microarray data were 
screened by GO terms (GO:0019827) related to stem cell maintenance. Among 
the 144 genes, 39 genes were up-regulated and 12 genes were down-regulated 
(Fig. 19D). Interestingly, these included core pluripotency markers including 
Oct4 and Nanog as well as other markers that have not yet been identified in 
pluripotency, such as Pecam1, Cnot1, Cldn6, Foxo1, Prdm14, and Otx2 (Fig. 
19D). These genes were also confirmed by real-time PCR (Fig. 19E). 
 
Gene expression profiles among eSLCs from three different origins 
In order to further investigate characteristics of eSLCs, IVP-eSLCs were 
compared with PA- or NT-eSLCs. First, I examined the pattern of DEGs 
between NT- and IVP-eSLCs and identified 895 DEGs, with 601 up-regulated 
and 294 down-regulated genes (Fig. 20A). Although 77 chromatin remodeling 
related genes (GO:0006338) were not in the major group, they were also 
profiled between NT- and IVP-eSLCs. Only 5 genes, Hmga1, Padi4, Chdil, 
Sycp3, and Padi2, were revealed as DEGs in this study (Fig. 20B), and their 
expression patterns were confirmed by real-time PCR (Fig. 20C).  
Next, the gene expression pattern in between PA- and IVP-eSLCs was 
analyzed. A total of 346 genes were differently expressed between PA- and IVP-











Figure 20. Comparison of differently expressed genes (DEGs) among 
embryo-derived stem-like cells (eSLCs) from three different origins. (A) 
Venn diagram of all DEGs in nuclear transfer-eSLCs (NT-eSLCs) and in vitro 
production-eSLCs (IVP-eSLCs). (B) Chromatin remodeling genes in NT-
eSLCs and IVP-eSLCs. (C) Gene expression profiles of DEGs related to 
chromatin remodeling. (D) Venn diagram of all DEGs in parthenogenesis-
eSLCs (PA-eSLCs) and IVP-eSLCs. (E) Imprinting genes in PA-eSLCs and 
IVP-eSLCs. The expression of paternally expressed imprinting genes is 
increased in PA-eSLCs compared with the gens in IVP-eSLCs, while 
maternally expressed imprinting genes are vice versa. (F) Gene expression 
profiles of DEGs related to imprinting. Somatic cells are also presented as a 




Although these were not in the major group, 12 imprinting related genes were 
included in these DEGs (Fig. 20E). Surprisingly, among these genes, PA-eSLCs 
had higher expression of Phlda2, Ascl2, H19, Meg3, Tssc4, and Igj2r as 
imprinted maternally expressed genes than IVP-eSLCs (Fig. 20F). On the other 
hand, the expression of 5 imprinted paternally expressed genes, Igf2, Snrpn, 
Nap1l5, Peg3, and Plagl1, was down-regulated in PA-eSLCs compared to IVP-
eSLCs (Fig. 20E). These genes were also confirmed by real-time PCR (Fig. 
20F).  
 
The expectation of signaling pathways for bovine pluripotency 
Although there are many studies of stem cells, little is known about the 
signaling pathways related to pluripotency in bovines. Therefore, the co-
expression pattern of whole genes in eSLCs may be a valuable tool for the 
discovery of important pathways related to pluripotency in bovines. To 
elucidate these pathways in more detail, I specifically searched for co-
expressed genes that may be related to signaling pathways for pluripotency, and 
the biological pathways were analyzed by the Kyoto Encyclopedia of Genes 
and Genomes (KEGG) database in bovines [62]. In co-up-regulated genes 
among eSLCs, I identified 2,415 DEGs, with 1,014 co-up-regulated genes and 
1,401 co-down-regulated genes (Fig. 21). By the KEGG database, there were 
54 signaling pathways in DEGs, and some of them were related to the 
maintenance of pluripotency, including TGFβ, WNT, and LIF signaling (Fig. 
21). In TGFβ signaling, the BMP family and SMAD family were contained in 








Figure 21. Differently expressed genes (DEGs) in embryo-derived stem-
like cells (eSLCs) and the analysis of distinct pathways related to 
pluripotency. In total of 10203 genes, the DEG numbers of in vitro production 
(IVP)-, nuclear transfer (NT)-, parthenogenesis (PA)-eSLCs are 3941, 4386 and 
4374, respectively. Among them, co-expressed DEGs are 2415 (23.6%). By 
KEGG analysis of the co-expressed DEGs, there are 54 signaling including 









Figure 22. BMP signaling pathway in embryo-derived stem-like cells 
(eSLCs). (A) KEGG pathway map of BMP signaling related to core 
transcriptional network for pluripotency. Most differently expressed genes 
(DEGs) related to BMP signaling are up-regulated in eSLCs compared with the 
gens in somatic cells. The boxes outlined with red indicate relatively up-
regulated DEGs. Fold change value is also provided with red in the table below 
(A). (B) Gene expression profiles of DEGs related to the BMP signaling 





In WNT signaling, 19 genes such as Wnt7a, Wnt10a, Fzd7, Dkk1, and Dvl1 
were included in DEGs, and core genes were confirmed by real-time PCR (Fig. 
23). In LIF signaling, Lif, Stat3, and Socs3 were identified as DEGs and 
confirmed by real-time PCR (Fig. 24). 
 
The expression pattern of tumor-related genes in eSLCs 
To elucidate abnormal teratoma formation in bovine eSLCs, I attempted to 
examine 82 oncogenes and 63 tumor suppressor genes among eSLCs, as 
described on the Cancer Genes website and via literature searches [63]. Among 
the oncogenes, 7 co-up-regulated genes and 23 down-regulated DEGs were 
identified in eSLCs (Fig. 25A). The expression of key genes in down-regulated 
DEGs was confirmed by real-time PCR (Fig. 25B). Among tumor suppressors, 
30 DEGs, with 21 co-up-regulated genes and 9 co-down-regulated genes were 
also identified (Fig. 25C). The expression of primary genes in up-regulated 
DEGs was confirmed by real-time PCR (Fig. 25D). 
I also investigated Defb1, Defb3, Defb7, and Smad3, which may be related 
to teratoma formation. Interestingly, according to the data, Smad3 expression 
was decreased, while the expression of Defb1, Defb3, and Defb7 was increased 
in eSLCs compared to SCs (Fig. 25E). These genes were also confirmed by 







Figure 23. The WNT signaling pathway in embryo-derived stem-like cells 
(eSLCs). (A) KEGG pathway map of WNT signaling related to core 
transcriptional network for pluripotency. Most differently expressed genes 
(DEGs) related to WNT signaling in eSLCs are up-regulated when compared 
with somatic cells (SCs), although some genes, such as Fzd1 and Apa, are 
down-regulated. Dkk1, Dkk3, and Sfrp2, inhibitors of BMP signaling, are down-
regulated in eSLCs. The boxes outlined with red indicate relatively up-
regulated DEGs, while the ones outlined with blue point to relatively down-
regulated DEGs. Fold change value is also provided with red (up-regulated 
genes) and blue (down-regulated genes) in the tables below (A). (B) Gene 
expression profiles of representative DEGs related to the BMP signaling 






Figure 24. LIF signaling pathway in embryo-derived stem-like cells 
(eSLCs). (A) KEGG pathway map of LIF signaling related to core 
transcriptional network for pluripotency. Lif, Lifr, and Socs3 genes are up-
regulated in eSLCs when compared with somatic cells, while the Stat3 gene is 
down-regulated. The boxes outlined with red indicate relatively up-regulated 
DEGs, while the ones outlined with blue mark relatively down-regulated DEGs. 
Fold change is also provided with red (up-regulated genes) and blue (down-
regulated genes) in the table above (A). (B) Gene expression profiles of DEGs 
related to the LIF pathway. ICM and somatic cell (SC) are also presented as a 










Figure 25. Oncogene- and tumor suppressor-related differently expressed 
genes (DEGs) in embryo-derived stem-like cells (eSLCs). (A) Venn diagram 
shows 7 up-regulated and 23 down-regulated DEGs related to oncogenes. (B) 
Gene expression profiles of representative differently expressed oncogenes. (C) 
Venn diagram shows 21 up-regulated and 9 down-regulated DEGs related to 
tumor suppressors. (D) Gene expression profiles of representative differently 
expressed tumor suppressors. (E) Venn diagram shows DEGs related to the 
Defensin family (tumor suppressor) and Smad3 (oncogene). (F) Gene 
expression profiles of DEGs related to the Defensin family and Smad3. ICM 








1. The generation of bovine eSLCs by somatic cell nuclear transfer  
The objective of the present topic was to establish bovine SCNT-eSLCs and to 
demonstrate their stem cell characteristics such as self-renewal, pluripotency 
and differentiation potentials. Although most early reports on the cultivation of 
bovine ES-like cells based on the system for mouse ESCs, failed to generate 
true bovine ESCs [6, 58-60], recent reports have demonstrated that treatment 
of cells with various small molecule inhibitors of FGF, MEK, and GSK3, can 
establish ESCs even for non-permissive species such as outbred mice and rats 
[3, 11]. FGF, MEK and GSK3 signaling pathways are important for stem cell 
differentiation and apoptosis in mammals [11, 16-19]. In my preliminary 
studies, three different culture media based on human and mouse ESC media 
with slight modifications failed to maintain putative bovine ESCs beyond the 
15th passage [64]. In recent reports, small molecules combinations were shown 
to efficiently establish ESCs [3, 15]. In my study, various combinations of three 
small molecule inhibitors were tested to investigate optimal culture media for 
bovine PSCs (Table 2); only the 3i supplemented medium maintained PSC 
colonies over 20. Although other studies have shown effectiveness of different 
combinations of small molecules [53], my results are in agreement with 
findings from experiments on parthenogenetic ESCs [15]. Furthermore, the 
efficacy of cell colonies establishment was approximately twice higher in the 




implying that the 3i culture system is appropriate to maintain bSCNT-eSLCs 
for long-term propagation.   
One of the fundamental properties of PSCs is continued proliferative self-
renewal. Indeed, CMt of bSCNT-eSLC colony also actively proliferated during 
culture (Fig. 6A) as indicated by positively labeling with BrdU. 
Characterization of stem cell properties in livestock ESCs routinely analyze AP 
activity [7]. Although there are species differences, staining for AP [7] activity 
is still an important criterion for identifying ESCs, especially in bovine studies 
where there lacks consensus on the use of other pluripotency specific markers 
such as SSEA-1, -3 and -4 [8, 9, 58, 65]. The bSCNT-eSLC colonies of the 
present study exhibited mosaic pattern of AP activity (Fig. 6B), with stronger 
AP staining in the CMt portion than the PMn, which may indicate a higher 
pluripotency potential of the central portion. Alternatively, heavy staining may 
also have contribution from the multilayers of cells in the central region or both 
(Fig. 6B). Previous studies have also shown heterogenous staining of AP 
activity in bovine ES-like cells [7, 61, 66]. 
The RT-PCR results suggest that the colonies cultured under the 3i system 
may include cells possessing pluripotency because they were positive for core 
pluripotency markers and importantly, positive for the naïve-specific markers 
(Fig. 6C). In many species including cattle, Rex-1 (Zfp42), Klf2, Klf4, Nrob1 
and Fgf4 are used as naïve pluripotency-specific markers, whereas Fgf5, T-
brachyury and Lefty2 are considered as primed pluripotency-specific [11, 53, 
67]. Unlike other naïve pluripotency markers, Fgf4 showed weak expression in 




is also well-known to induce trophoblast stem cells (TSCs) in mice [68] and the 
gene was expressed in bovine TE as well (Fig. 6C). The small molecule 
inhibitors of the 3i system may interrupt or suppress differentiation into 
trophoblastic lineage and may help eSLCs to maintain their PSC character.  
It has been documented that Rex-1 is important for maintenance of 
pluripotency and is one of the key factors used to distinguish naïve and primed 
state pluripotency [11, 67]. Rex-1 was reported to be expressed in both ICM 
and TE of bovine blastocyst [55]. However, in the present study, Rex-1 was only 
detected in ICM of the blastocyst and cultured bSCNT-eSLCs. Different from 
other primed state PSC markers such as T-brachyury and Lefty2, only Fgf5 was 
expressed in bSCNT-eSLCs. This suggests that 3i culture system may still 
require additional component factor(s) to completely maintain naïve state 
pluripotency in cultured bovine embryonic cells. All primed state PSC markers 
were not detected in whole blastocysts, ICM and TE as these genes are normally 
expressed after implantation [69].  
In the present study, it is necessary to use whole blastocyst stage embryo 
for the generation of bSCNT-eSLCs although the cells were from PMn part of 
the colony which included ICM-derived cells. Therefore, TE from bovine 
blastocyst was also analyzed with various specific markers for pluripotency and 
TE (Fig. 6C) to characterize the cultured cells. Different from bSCNT-eSLCs, 
only Oct4, Dppa3, Fgf4 and TE specific markers were expressed in bovine TE 
in this study. Oct4 was expressed in both bSCNT-eSLCs and TE whereas the 
expression of Nanog was only observed in bSCNT-eSLCs. According to some 




expression did not differ between ICM and TE while Nanog expression was 
significantly higher in ICM than TE [28, 70]. It is interesting to note that Dppa3, 
unlike other pluripotency specific markers, is expressed in murine ICM [71], 
and was also expressed in bovine TE (Fig. 6C). This finding may be related to 
the expression of Oct4 [72] in bovine TE cells in this study.  
In the mouse, TE specific markers are not expressed in embryo-derived 
PSCs including ICM and ESCs [73, 74]. However, bSCNT-eSLCs generated 
and maintained in the 3i system expressed some of the TE specific genes such 
as Cdx2, Tead4 and Inf-tau. This may suggest that the regulatory genes and 
mechanism related to pluripotency maintenance in human and mouse does not 
completely match with the ones in cattle. In the present study, Cdx2 which 
regulates TE cell fate and is expressed in TE of murine blastocyst, was also 
expressed in ICM (Fig. 6C) as previously reported [55, 70, 75], although the 
expression level was lower than in TE. These results provide a clue as to why 
the establishment and maintenance of genuine embryonic PSCs are difficult in 
ruminant animals such as cattle [5, 6, 9, 15, 26]. Various genes participate in 
differentiation of embryonic cells into TE lineage [54, 69, 76]. According to the 
reports, both Elf5 and Hand1 are involved in TE differentiation both in murine 
species and in bovine species. Different from TE cells, Elf5 and Hand1 were 
not expressed in bSCNT-eSLCs in this study, providing support for the notion 
that bSCNT-eSLCs in 3i system may not be analogous to TSCs or TE cells [69, 
76], although some TE specific genes were expressed.  
Immunofluorescence analysis using specific antibody probes to OCT4, 




characteristics of pluripotency in bSCNT-eSLC colonies. Unlike the AP 
expression, these markers were not uniformly expressed throughout the colony 
(Fig. 7). Most markers were localized only in the CMt portion of the colony, 
suggesting that the colony might consist of cell type(s) in addition to the pure 
PSCs. Nevertheless, the positive expression of the battery of pluripotency 
markers demonstrates that the ESC culture method used in this study, the 3i 
system, is competent to maintain the stem-ness of bSCNT-eSLCs by inhibiting 
differentiation and supporting pluripotency, even though not all areas of the 
stem cell colony displayed positive expression of the markers. However, the 
non-uniform marker expression may also be characteristic of bSCNT-eSLCs 
like that of human ESCs [77]. 
This study investigated the differentiation potential of bSCNT-eSLC 
colonies using both in in vitro and in vivo assays because there have been a few 
attempts to verify the in vitro differentiation potentials [9] and no reports of the 
in vivo differentiation potentials. As has been demonstrated for other ESCs, EBs 
could be formed from bSCNT-eSLCs in vitro and categorized into two types by 
their shape, cystic and solid (Fig. 8A). Both types of EBs were able to grow for 
more than 10 days while retaining their morphology Furthermore, these EBs 
expressed three germ layer markers similar to human and mouse EBs (Fig. 8B) 
[1, 2], which is different from simple clusters of differented cells or 
trophoblastic vesicles [78]. In the present study, I also studied the in vivo 
differentiation potential of bSCNT-eSLCs after transplantation in nude mice. 
However, I did not recover true teratomas demonstrating differentiation into all 




(Fig. 9). In addition, the formation rate of the tumors was also very low (Table 
9), perhaps due to insufficient number of stem cells in whole colony [53, 65]. 
Although the tumors did not represent authentic teratomas, they displayed 
typical embryonic carcinomas (ECs) with large primitive cells with areas of 
glandular and papillary formations (Fig. 9A-F). To the best of my knowledge, 
the present study is the first report demonstrating the differentiation potency of 
PSCs in vivo as well as in vitro using SCNT-eSLCs in cattle. 
Unlike human and mouse, previous bovine PSC studies have been limited 
to description of the pluripotency of colonies [5, 8, 9, 15, 26]. Hence the present 
study was undertaken to explore further properties of bovine eSLCs. First, the 
colony was divided into two parts as CMt and PMn. The region of CMt shows 
smaller and concentrated shape while the region of PMn is analogous to 
trophoblastic or epithelial cells, revealing large and flat morphology (Fig. 4). 
Intriguingly, after passaging of CMt and PMn parts separately, they presented 
different morphologies (Fig. 11A). The CMt-derived colonies after passaging 
subculture contained not only small and condensed CMt part cells, but also 
large and flat PMn part cells. On the other hand, the PMn-derived passaged 
colony only possessed PMn part cell population. The outgrowth rate and the 
number of AP-positive colonies in CMt-derived colonies were markedly higher 
than in PMn-derived colonies (Table 6). In addition, some PMn-derived 
colonies showed very weak AP activity, considering that the PMn-derived 
colonies may include very few numbers of eSLCs when compared with CMt-
derived ones. Some reports showed that bovine trophectoderm is positive to AP 




Table 9. Teratoma-like tumor formation after transplantation of bSCNT-eSLCs* 
 
No. 
Injection into testis 
Teratoma-like tumor 
formation 
bSCNT-eSLCs 10 1 (embryonic carcinoma) 
STO (feeder cells) 6 0 





trophectodermal cells) were positive for AP staining in the 3i conditions of this 
study, which is consistent with other reports [59, 80]. This suggests that 3i 
culture condition may be insufficient to retain AP activity in PMn, different 
from the activity in CMt. As a result, the CMt-derived colonies continue to 
proliferate while the number of PMn-derived colonies decreased and ultimately 
failed to sustain during the passaging. Quantitative PCR analyses revealed 
higher expression of pluripotency specific markers in the CMt region compared 
to those in the PMn region, whilst TE specific marker expression was opposite 
in direction (Fig. 12). Numerous studies of bovine eSLCs or ES-like cells 
reported that the cells show TSC-like morphology, in addition to their ESC 
morphology [9, 15, 32, 58, 59, 66] and it may be important to discover the 
differences between eSLCs and TSCs. Like those studies, the morphology of 
PMn in the present study is similar to TSCs or trophoblastic cells. Oct4 is an 
essential transcription factor to maintain pluripotency and the gene sequence is 
highly conserved in mammals [81].  
Oct4 is found in various PSCs and is used as the core reprogramming factor 
to generate somatic cell-derived induced PSCs. In mice, Oct4 is expressed in 
early blastomere and only ICM-specific expression was observed at the 
blastocyst stage which is the first determination stage of cell fate between ICM 
and TE. This, suggest that Oct4 plays an integral role in cell fate determination 
during early mammalian development. Cdx2 is generally considered to be an 
arbiter of trophoblastic cells and required to restrict Oct4 expression to ICM of 
the embryo [74, 82]. Indeed, Cdx2 is expressed in TSCs [74, 82] arising from 




generally accepted that Oct4 and Cdx2 expressions are hallmarks to identify 
and characterize the status of embryo-derived cells. Due to failure to retain the 
colony under 3i system when TE and ICM were separated (Table 10), the whole 
blastocysts were used in this study and the expression of TE-specific markers 
were also determined. Formation of stem-like cell colony which can be 
generated only from whole blastocysts implies that CMt (mainly from ICM) 
and PMn (mostly from TE) may be interdepentant during the establishment and 
maintenance of eSLCs in vitro under 3i system.  
Co-localization of OCT4 and CDX2 throughout the colony implies that 
bSCNT-eSLCs contain TSC population and/or the cells have dual properties. 
Interestingly, OCT4-positive cell without CDX2 expression were largely 
restricted to the CMt part of the colony (Fig. 10A-C). However, recent studies 
showed that OCT4 is also expressed in bovine trophoblastic cell line [76], 
implying that OCT4 may not be a good PSC marker in bovine species. Different 
from OCT4, NANOG is not detected in bovine trophoblastic cell line [76] and 
is also known as a naïve pluripotency marker [53], although a recent report 
showed the presence of mRNA in bovine TS-like cells. Here, I showed that the 
NANOG-positive cell population without CDX2 expression was limited to 
CMt part in the colony like OCT4-positive cells (Fig. 10B, F). The bSCNT-
eSLC colonies in the present study expressed most pluripotency specific 
markers although they also expressed some marker genes specific for TE. In 
particular, the naïve pluripotency specific markers such as Rex-1, Klf2, Klf4 and 
Nrob1 were highly expressed in bSCNT-eSLCs which were not expressed in 




 Table 10. The survival rate of CMt- and PMn-derived coloniesa) 
a)CMt: central multilayer; PMn: peripheral monolayer. 
b)Only one colony slice were used for the next passage. The CMt colony was sliced to 4 pieces 
while the PMn colony was sliced to 2 pieces due to the inability of attachment and proliferation 
of the cells in PMn colony in 3i culture condition. 
c)Outgrown seeded blastocysts = Passage 0 
d)Until passage 21, the stem cell colony was maintained only with CMt-derived cells. Up to 
passage 21, PMn part of the colony was discarded. 
  
   No. of survived colonies at 
  Groupb) Passage 1  Passage 2  Passage 3  Passage 4 
Passaging the 
initial stage of 
coloniesc) 
CMt 
C1 1 3 10 29 
C2 1 2 6 18 
C3 1 2 4 8 
C4 1 2 6 16 
C5 1 2 5 15 
Total (%) 5 (100.0) 11 (55.0) 31 (70.4) 86 (69.3) 
PMn 
P1 1 2 1 0 
P2 1 2 2 0 
P3 1 0 0 0 
P4 1 1 0 0 
P5 1 0 0 0 
Total (%) 5 (100.0) 5 (50) 3 (25) 0 (0) 
 
  No. of survived colonies at 






C1 1 4 13 
C2 1 3 8 
C3 1 2 5 
C4 1 2 11 
C5 1 3 4 
Total (%) 5 (100) 14 (70) 41 (73.2) 
PMn 
P1 1 0 0 
P2 1 0 0 
P3 1 1 0 
P4 1 0 0 
P5 1 1 0 




The results above suggest that a part of the colony, mostly maintained and 
propagated in CMt area, is at pluripotency and the cells are different from 
trophoblastic cells. However, bSCNT-eSLC colony in 3i system includes sub-
populations of more than one type of cells including TE specific marker 
expressing cells. Recently, TS-like cells were generated by the treatment of 2 
inhibitors, which had used previously characterized PSCs from many species 
including cattle [3, 11, 53, 69]. Although there are some similar features (eg. 
Morphology), the cell colonies under 3i condition not only express core or 
primed pluripotency markers, but also many naïve state markers. Moreover, the 
cells were able to differentiate into three germ layers in vitro. It was also 
reported that some trophoblastic markers are expressed in ICM-derived cells 
[83]. Considering these results, the eSLC colonies under 3i condition are 
different from previous PSCs cultured with 2 inhibitors including recent TS-
like cells. 
 
2. Enhancing pluripotency of bovine eSLCs 
The characteristics that define ESC such as morphology, expression of specific 
markers and activation of signaling pathways for maintenance of pluripotency 
and self-renewal, are well known in mice and humans [84]. However, in cattle, 
methods for the establishment of genuine ESC and their specific characteristics 
have not yet been defined [80]. 
The objectives of the present study were to establish PSCs from blastocysts 
of cattle and demonstrate the effect of thiazovivin on the generation and 




treatment improves the generation of iPSCs and ESC of mice and humans [37], 
because ROCK inhibitors are known to improve the survival of various kinds 
of stem cells, including ES, iPSCs and adult stem cells [36, 37, 85]. thiazovivin, 
a ROCK inhibitor, was utilized in the present study to establish eSLCs. The 
effects of thiazovivin on the plating efficiency of seeded blastocysts and the 
survivability and the proliferation of putative SLC were subsequently 
investigated.  
Small molecules can play an important role in both the propagation of ESC 
and the generation of iPSCs by enhancing their pluripotency, self-renewal or 
cellular reprogramming [35]. One of these small molecules, thiazovivin, 
improves survival and proliferation of ESC via the stabilization of the E-
cadherin protein through direct inhibition of ROCK [37]. E-cadherin-related 
cell-cell contact controls survival and self-renewal of human ESC [37, 38]. Fate 
and function of various stem cells are influenced by the extra-cellular matrix 
(ECM) both in vitro and in vivo. Cell-ECM interactions are important for the 
attachment, proliferation, differentiation and survival of stem cells. 
In the generation of ESC lines, the initial stages including outgrowth of cell 
clumps and formation of colonies from the zona pellucida-free blastocyst are 
important for the subsequent steps in long-term culture and propagation of ESC 
[86]. In humans, subculture of ESC is performed by mechanically splitting the 
cell clump. However, subsequent attachment of some of these clumps to the 
feeder layer is poor, and this step is very important to form an ESC colony [87]. 
Because previous studies utilized buffalo and cattle ES-like cells also used a 




it is likely that the initial attachment of the embryonic cell clump may also be 
a critical step to generate ESC from cattle. Recent data show that existence of 
cell populations expressing the Cdx2 and Ifn-tau genes (TE-specific markers) 
supports the maintenance of pluripotency and propagation of eSLCs of cattle 
over 50 passages, although there are some eSLC populations expressing only 
pluripotency markers without TE-specific marker expression [30]. In the 
present study, the culture peripheral trophoblastic part of eSLC colonies under 
the 3i system was attempted. However, unlike eSLCs of cattle, the cells could 
not grow and/or be maintained in 3i medium although few attached clumps 
could only form primary colonies (Table 7) [30]. The results also suggest that 
eSLCs of cattle in the 3i system may not be analogous to TE or trophoblast stem 
cells, although some TE-specific genes are expressed [30]. The eSLCs of cattle 
display a flat-shaped morphology similar to human ESC. Interestingly, eSLCs 
of cattle express core, naïve state pluripotency and primed state pluripotency 
gene markers together, although the cells are similar to murine naïve state 
pluripotent cells (Fig. 14C) [30]. 
At this stage, in ESC generation, cell-cell contact and/or attachment to 
feeder layer cells are critical. Therefore, in the present study, thiazovivin, a 
ROCK inhibitor, is utilized while culturing the ICM or whole blastocysts 
seeded on the feeder cells, in an effort to improve embryo-derived cell 
attachment. Regardless of the cell’s type, thiazovivin improved the attachment 
rate to the feeder cells. Although isolated ICM tended to demonstrate higher 
attachment efficiency, the primary colony forming efficiency was significantly 




thiazovivin treatment increases the attachment rate of zona-free blastocysts and 
consequently, the outgrowth rate of primary colonies. Both of them are critical 
initial steps for the generation of eSLCs of cattle.  
After the primary colony formation, putative cattle eSLC colonies were 
subcultured over 25 passages, and the cells showed a normal karyotype. The 
Oct4 and Nanog pluripotency markers were analyzed by RT-PCR and qPCR. 
Expression of the Oct4 gene and Nanog mRNA tended to be increased by 
thiazovivin treatment. Previous studies demonstrated that the addition of a 
ROCK inhibitor improved survival and proliferation of human ESC and 
mesenchymal stem cells [36]. The inhibitor increased the expression of the 
Oct4 gene in human ESC and the expression of the Nanog gene in buffalo ES-
like cells [85]. In the present study, Oct4 gene expression was increased by 
thiazovivin treatment of eSLCs of cattle, implying that thiazovivin may 
enhance the potential for pluripotency in the eSLCs. However, AP activity and 
immunofluorescence staining results were not different from those in the 3i 
control group. Partial staining of AP activity in SLCs is in agreement with other 
studies with cattle [66]. In addition, thiazovivin treatment resulted in larger 
eSLC colonies in cattle (Fig. 15). The ability of eSLCs of cattle to undergo 
cellular differentiation was not changed by thiazovivin treatment. This is in 
agreement with a previous study that examined another ROCK inhibitor, which 
demonstrated that the differentiation potential was not significantly improved 
by Y-27632 treatment in buffalo ES-like cells, although the primary colony 
formation rate was increased by the treatment [85]. 




by thiazovivin increased the survival and adhesion of human ESC by stabilizing 
E-cadherin in the cell membrane [37]. Hence, the changes in E-cadherin gene 
expression in the present study were induced by thiazovivin treatment as 
evidenced by immunofluorescence staining and real time PCR analysis. The 
greater fluorescence intensity of E-CADHERIN and the elevated E-cadherin 
gene expression in thiazovivin-treated cells suggests that the enhancement of 
E-cadherin by ROCK inhibition may support the survival and adhesion of 
putative eSLCs of cattle, as in the case with human ESC. Additionally, this may 
result in the improvement of the maintenance of stemness of eSLCs of cattle. 
 
3. Microarray analysis of bovine eSLCs  
The microarray technology has revealed a powerful tool for profiling the global 
gene expression and DEGs are suggested specific or universal characteristics. 
To understand their characteristics, PSCs in many species including humans 
and mice have been analyzed by this technology. However, it is still not well 
known yet about gene expression profiles of embryo-derived PSCs in cattle. In 
the present study, I analyzed the gene expression pattern of bovine eSLCs from 
three different origins: IVP-, NT-, and PA-blastocysts. These were compared 
with each other to understand their shared and distinct properties. In addition, 
these were compared with SCs to understand shared pathways for pluripotency 
and failure of teratoma formation by profiling tumor-related genes and tumor 
suppressor genes.  
To understand characteristics of eSLCs and SCs, I analyzed their gene 




expression among six different eSLCs, while all the eSLCs have immensely 
different gene expression from SCs (Fig. 19A), suggesting that properties of 
eSLCs may be significantly different from those of SCs.   
To further verify differences between eSLCs and SCs in detail, IVP-eSLCs 
were compared with SCs. Among up-regulated DEGs, most GO terms in the 
BP group were related to metabolic activity and the cell cycle (Fig. 19C). 
Generally, the cell cycle of ESCs is shorter than that of SCs, because the 
durations of G1 and G2 are remarkably decreased [88]. This means that there 
is a rapid onset of stem cell proliferation and an enormous demand for energy, 
such as ATP. Because of this, the metabolic system in ESCs is also changed 
[89]. Consequentially, metabolism-related genes in ESCs were up-regulated 
compared to SCs. The results suggest that the metabolic system of IVP-eSLCs 
may be similar to ESCs and that they may have a short cell cycle, consistent 
with my previous report [30].    
Expression of pluripotent genes and inhibition of differentiation genes are 
both necessary for maintenance of a pluripotent state. Recently, it has been 
documented that mESCs are able to maintain their unique properties, including 
self-renewal and potential of differentiation, by using inhibitors which suppress 
differentiation signaling pathways [11]. More recently, bovine eSLCs were also 
derived with these inhibitors [30]. According to the results in down-regulated 
DEGs, most GO terms in the BP group were related to differentiation and 
development (Fig. 19C). These results suggest that the expression of 
differentiation-associated genes in bovine eSLCs is decreased when compared 




differentiate in bovine eSLCs. These results may help to retain pluripotency in 
eSLCs.   
One of the biggest differences between ESCs and SCs is the expression of 
pluripotent genes [90]. Comparing with SCs, eSLCs expressed 39 pluripotent 
DEGs including the core pluripotency markers, Oct4 and Nanog. It has been 
documented that Oct4 and Nanog expressions are essential not only to decide 
first cell fate, trophoblast and ICM, but also to maintain pluripotency of stem 
cells in mouse, as well as human [91]. In bovine, it has been also revealed that 
Oct4 and Nanog are also expressed in embryos and embryo-derived cells [30]. 
Moreover, the overexpression of two genes was essential to generate bovine 
iPSCs [20]. These previous reports and the results suggest that Oct4 and Nanog 
expressions may be indispensable to support bovine ESCs. Among these DEGs, 
some pluripotency related genes are well known in mESCs and hESCs, but have 
not yet been reported in bovine embryo-derived cells; these include Pecam1, 
Cnot1, Otx2, Prdm14, and Cldn6 (Fig. 19D). These genes have been well-
known as pluripotency markers in mESCs [92-96]. In this study, these up-
regulated DEGs were also confirmed by real-time PCR and the results revealed 
that these genes were significantly increased in IVP-eSLCs compared to SCs 
(Fig. 19E). Surprisingly, their expression was similar in IVP-eSLCs and ICM, 
implying that these genes may act as pluripotency markers and can aid in 
distinguishing the population of true PSCs in bovines. 
Recent evidence suggests that ESCs from NT- and PA-embryos contribute 
epigenetic modifications such as chromatin remodeling and imprinting [97, 98]. 




might be useful for predicting epigenetic deficiencies that induce unsuccessful 
development.  
Although NT-embryos are produced by oocyte-derived reprogramming 
factors like IVP-embryos, the efficiency was extremely low and transcriptional 
abnormalities were revealed [99]. The major cause of these developmental 
failures may be due to epigenetic modifications such as chromatin remodeling 
[100]. Profiling of chromatin remodeling-related genes revealed 5 genes that 
were differentially expressed between IVP- and NT-eSLCs (Fig. 20B and C). 
The expression of Hmga1, PadI4, and Chd1l was significantly increased in NT-
eSLCs compared to IVP-eSLCs (Fig. 20B and C). Interestingly, these genes 
were not only related to chromatin remodeling, but were also associated with 
pluripotency. [101, 102]. They may be sufficient to trigger a cascade of 
epigenetic problems, leading to low efficiency of differentiation and 
development of the NT-embryo, despite the small number of DEGs. 
Comparisons between PA- and IVP-eSLCs revealed differences in 
imprinting gene expression, which is consistent with a previous study [49]. 
Although the expression of some genes did not increase exactly two fold, an 
increasing trend for imprinted maternally expressed genes and a decreasing 
trend for imprinted paternally expressed genes in PA-eSLCs by real-time PCR 
were observed when compared to IVP-eSLCs (Fig. 20E and F). PA-eSLCs 
maintained an abnormal expression pattern of imprinting-related genes, like the 
PA embryo, and may be useful for preventing the waste of embryos in 
imprinting studies.  




[26, 58, 65]. However, there have been no reports that identify signaling 
pathways that maintain PSCs. In order to verify the appropriate pathways 
associated with bovine pluripotency, I investigated and analyzed co-regulated 
genes among eSLCs with the KEGG database. According to the results, co-
regulated genes associated with pluripotency are strongly related to the TGFβ, 
WNT, and LIF signaling pathways (Fig. 21). 
Although BMP signaling, which belongs to the TGFβ superfamily, 
promotes non-neural differentiation, BMPs also maintain pluripotency by 
activation of inhibitor of differentiation (Id) genes [10]. In addition, in mice, 
BMPs are able to support pluripotency in the absence of both serum and feeder 
cells [13]. Moreover, recent evidence has revealed that BMP4 plays an 
indispensable role in establishing bovine iPSCs [103]. Although some genes 
were down-regulated in this study, core BMP signaling genes appeared in co-
up-regulated DEGs. In particular, Bmp4, Bmp7, Bmpr1a, Smad4, Smad5, and 
Id1 were up-regulated (Fig. 22A and B). Interestingly, the expression pattern of 
these genes in all eSLCs was similar to that of ICM, suggesting that BMP 
signaling may be activated and may support pluripotency of bovine eSLCs, 
similar to the role of ICM in embryos. 
The WNT pathway is also important for the enhancement of proliferation 
and maintenance of pluripotency in ESCs, as it stabilizes cytoplasmic b-catenin 
by suppressing GSK3β [12]. According to this results, WNT signaling genes 
such as Wnt7a, Wnt10a, and Fzd7 were involved in co-up-regulated DEGs (Fig. 
23A and B). Moreover, Dvl1 and β-catenin, which are downstream of WNT 




and Dkk3, which are suppressors of WNT signaling, were down-regulated in 
bovine eSLCs (Fig. 23A and B). Interestingly, this gene expression pattern was 
similar to that revealed in ICM (Fig. 23B). These results suggest that the WNT 
pathway may be activated as one of the strongest regulators to support 
pluripotency in bovine eSLCs.  
Recently, it has been documented that LIF signaling is essential in mESCs 
and naïve hESCs [104]. In this results, LIF signaling also appeared in DEGs. 
The expression of Lif and Lifr genes was up-regulated, while Stat3 expression 
was down-regulated in eSLCs (Fig. 24A). Surprisingly, the expression of Stat3 
in eSLCs was in reverse of its expression in ICM, suggesting that the signal 
transmission between LIF and STAT3 may be disconnected. It has been 
reported that many culture systems in previous studies, even those including 
LIF, fail to generate true bESCs [6, 28, 29]. According to this results, the failure 
may be related with the disconnection between LIF and STAT3. For the 
maintenance of pluripotency in bESCs, the LIF signaling pathway may be 
activated by STAT3 signaling and/or downstream effectors which do not 
supplement or stimulate LIF itself.  
SOCS3 inhibits JAK signaling by a binding mechanism, resulting in the 
inhibition of the LIF pathway for pluripotency [105]. According to the 
microarray and real-time PCR results, Socs3 expression was significantly up-
regulated in eSLCs compared to SCs (Fig. 24). Assuming that the increased 
expression of Socs3 may inhibit JAK signaling, this may be a critical factor 
involved in destruction of the LIF pathway. This study therefore suggests that 




bovines, and Socs3 inhibition may generate authentic bESCs.  
Generating eSLCs in a 3i culture system with long-term proliferation and 
expression of pluripotent markers has been previously successful. However, the 
efficiency of in vivo differentiation is extremely low and teratoma formation 
was induced abnormally [30]. Many previous studies in the literature have also 
revealed similar problems [26, 53, 59], even in bovine iPSCs [20].  
It was hypothesized that tumor-related genes may be changed in eSLCs, so 
I profiled oncogenes and tumor suppressor genes. Interestingly, among DEGs, 
most oncogenes (23 genes) were down-regulated, including Smo, Bcl11a, 
Maml2, and Ccnd1 which are related to tumors and metastasis [106-109] (Fig. 
25A). These results suggest that decreased oncogenes may reduce the frequency 
of teratoma formation and immature teratomas. In contrast, most tumor 
suppressor genes (21 of 30 genes) were highly up-regulated in eSLCs including 
Brca1, Mlh1, Msh2, Suz12, and Socs1, which are related to an increased risk of 
cancer [110-114]. These results indicate that up-regulation of these tumor 
suppressor genes may be associated with suppression of teratoma formation in 
bovine eSLCs.  
Some genes that affect teratoma formation are not tumor-related. The 
defensin family is a well-known immune system-connected factor [115] that 
can suppress tumor formation [116]. I observed increased expression of 
defensin family genes including Defb1, Defb3, and Defb7 (Fig. 25E and F). 
These results show that defensin family genes may also be candidates for 
teratoma formation in bovines. It has also been documented that Smad3 is the 




proliferation, pluripotency, and differentiation [117]. Recently, it has been 
reported that Smad3 is closely connected with teratoma formation from ESCs 
[118]. Smad3 expression was down-regulated (Fig. 25E and F). It is speculated 
that decreased Smad3 gene expression may be one of the reasons why teratomas 







In conclusion, the purpose of this study was to generate PSCs from bovine 
embryos by suppressing differentiation and to analyze them to discover the 
characteristics of bovine specific PSCs. To investigate this issue, three 
experiments were conducted.  
In the first experiment, several small molecules were tested as suppressors 
of differentiation, and as a result, finally, three inhibitors (3i) were selected. 
The cells in 3i were able to proliferate and were maintained in culture for over 
50 passages with the normal karyotype and pluripotency markers. Although the 
cells were still defined as eSLCs because of their incomplete capacity for in 
vivo differentiation, the cells had OCT4-positive or NANOG-positive cell 
populations without CDX2 expression. It suggests that there are some 
populations which have true pluripotency in the 3i system. Although the 
existence of pluripotent stem cells in 3i was confirmed, there are still unsolved 
problems to achieve authentic pluripotency. To investigate these issues, I 
focused on finding a small molecule to improve pluripotency and ultimately 
selected thiazovivin, a ROCK inhibitor. Thiazovivin treatment enhanced the 
attachment and outgrowth of the blastocyst and primary eSLC colony 
propagation after subculturing on the feeder layer cells. This effect may result 
from an increase in E-cadherin caused by the thiazovivin induced ROCK 
inhibition. However, the treatment of thiazovivin was not enough to transform 




the efficiency of teratoma formation. To elucidate the limitations of the eSLCs, 
microarray analysis was used to investigate their transcriptome. From this 
analysis, it was shown that various gene expressions for pluripotency were 
mostly upregulated in the eSLCs, and bovine specific pathways for 
pluripotency were also shown by the microarray analysis. It was also suggested 
that the low efficiency of teratoma in the eSLCs may be related to the gene 
expression patterns of oncogenes and tumor suppressors. Moreover, embryo 
specific gene expression patterns such as imprinting or chromatin remodeling 
were confirmed to be maintained in eSLCs from the embryos, suggesting that 
eSLCs in 3i could be used in the functional research of genes like mESCs or 
hESCs.   
Taken all together, the results of this research have increased our 
understanding of the state in bovine PSCs, and further investigation of the 
signaling pathway for pluripotency in eSLCs may be useful for the generation 
of genuine bovine ESCs. Furthermore, this study provides new insights into the 
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배아줄기세포는 자가증식능력과 모든 세포로 분화할 수 있는 
전분화능을 가지고 있다. 이러한 두 가지 특징 때문에 
배아줄기세포는 동물 및 사람의 다양한 기초연구에 활용되고 있다. 
오랫동안 소에서도 배아줄기세포를 생산하기 위한 노력이 있었으나, 
진정한 의미의 배아줄기세포는 아직까지 보고된 바 없다. 본 
연구에서는 소분자물질을 포함하는 배양액을 통해 소 
배아줄기세포를 확립하고 다양한 분자생물학적 기법을 통해 그 
성상을 분석하였다. 이러한 연구를 위해 먼저 배아줄기세포 생산에 
적합한 소분자물질을 선별하고 증식력, 전능성 마커 및 분화능 
검증을 포함하는 전분화능 줄기세포의 지표를 통해 배양된 세포의 
성상을 분석하였다. 마이크로어레이를 통해 전사체 분석을 
실시하였으며 관련된 차별발현유전자는 Real-time PCR기법을 통해 
검증하였다. 또한 전분화능 관련 신호경로는 KEGG분석을 
이용하였다. 생산된 배아줄기세포는 단층의 평평한 형태를 보였으며 




정상적인 핵형 및 전분화능 유전자발현을 보이며 50계대 이상 
증식이 유지되었다. 비록 불완전한 체내분화능 때문에 
유사배아줄기세포로 정의하였지만, 생산된 세포내부에 Cdx2의 
발현없이 Oct4 또는 Nanog 유전자 만 발현하는 전분화능 
세포집단의 존재를 확인하였다. 전분화능을 향상시키기 위해 
티아조비빈을 처리한 결과 배반포 부착 및 계대 후 증식력이 
유의적인 차이를 보이며 증가하는 것을 확인하였다. 또한 전분화능 
및 E-cadherin 유전자발현 역시 티아조비빈을 처리한 실험군에서 
증가하였으나 여전히 체내분화능을 향상시키는 데는 실패하였다. 
유사줄기세포의 한계를 분석하기 위해 마이크로어레이 분석을 
진행하였다. 암과 관련된 유전자분석결과 발암유전자는 감소하고 
항암유전자는 증가하였다. 이러한 결과는 배양된 줄기세포의 
체내분화능이 약화된 원인과 관련이 있을 것으로 생각된다. 또한 
TGFβ, WNT 그리고 LIF 신호경로가 소 전분화능 유지와 밀접한 
관련이 있는 것으로 확인되었다. 다른 두 신호경로와 달리 LIF 
신호경로는 비활성화 되어있어 LIF 신호경로의 재활성이 완전한 
전분화능 획득에 중요한 역할을 할 것으로 생각된다. 결론적으로 본 
연구에서는 세가지 억제제를 이용해 유사배아줄기세포를 
생산하였다. 또한 세포의 성상을 검증하는 동안 소 전분화능 유지 
한계의 원인을 규명하였다. 이러한 결과는, 소에서 특징적으로 
나타나는 전분화능에 대한 이해를 넓히고, 나아가 대동물 유래 
배아줄기세포 확립에 큰 도움을 줄 것으로 생각된다.  
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